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Abstract 
Since the sequencing of the Canis lupus familiaris genome the dog has become a 
powerful tool for scientists. Selective breeding has created more than 400 different 
breeds each representing genetic isolates with breed-specific morphological and 
behavioral characteristics. Unique population history, available genealogical records, 
veterinary diagnostics and novel genomic tools greatly facilitate gene mapping 
studies in dogs. Given that over 600 genetic disorders have been described in dogs 
and  that  most  of  them  are  similar  to  human  conditions,  dogs  have  emerged  as  a  
clinically relevant model for human inherited disorders.  
This study explores the genetics of three different inherited developmental 
defects in dogs, caudal dysplasia, ectodermal dysplasia, and mucopolysaccharidosis 
VII, which all have counterparts in human. In this study, various clinical and 
pathological techniques have been used to characterize the phenotypes, and genetic 
methods such as genome-wide association studies and next-generation sequencing to 
resolve the genetics of the diseases.  Moreover, functional studies in mice have been 
performed to explore the molecular role during embryonic development. The 
discoveries made here have established the affected breeds as models to further 
explore disease mechanisms and therapeutic methods, identified new disease 
pathways, and offered novel approaches for further developmental studies. 
Furthermore, this work has enabled the development of genetic tests for breeding 
purposes. 
Three different phenotypes have been investigated in this study. First, we studied 
genetics of caudal dysplasia, which in its mildest form is presenting as short-tail 
phenotype in dogs. A mutation in T (brachyury homolog) was earlier identified to 
cause this phenotype in Pembroke Welsh Corgis. Homozygous mutations of T in 
mouse result in severe caudal dysplasia and embryonic lethality suggesting an 
essential role for the T gene during mammalian development. The presence of the 
documented T mutation, c.189C>G, was investigated in 23 other breeds 
demonstrating that short-tailed dogs from 17 breeds were heterozygous for the 
mutation that associated completely with the phenotype. The homozygous mutation 
was suggested to be lethal, as no dogs homozygous for the mutation were found and 
an approximately 30% decrease was seen in the size of Swedish Vallhund litters 
when both parents were short-tailed. However, short-tailed dogs were found from six 
breeds that did not carry the known substitution or any other mutations in the T 
coding regions and therefore other genetic factors are yet to be discovered that affect 
the development of the posterior mesodermal region. The short-tailed dogs which do 
not have T mutation will serve as models in future studies to identify possible novel 
genetic factors for caudal dysplasia and related medical conditions. 
Second, a new gene was identified for a hairless phenotype and some of its 
upstream regulators were characterized. Hairless dog breeds show a breed 
characteristic which is in clinical terms an ectodermal dysplasia. In this study, the 
causative mutation for canine ectodermal dysplasia (CED) was sought and 
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subsequently the function of this novel gene in the ectodermal organ development 
was explored. Accordingly, a genome-wide association study was performed and 
CED was mapped to dog chromosome 17. Haplotype association testing revealed a 
160-kb haplotype, which was fine-mapped using three different breeds. The 
causative genetic mutation for CED was identified as a 7-bp duplication producing a 
frameshift and premature stop codon in a previously uncharacterized canine gene 
forkhead box protein I3 (FOXI3). The study provided a novel gene focus to aid 
research into ectodermal development. Therefore, a detailed expression pattern of 
murine Foxi3 during the development of the ectodermal organs was constructed and 
a series of tissue culture experiments and expression analyses with mouse embryos 
were performed to assess the function of Foxi3 in mammalian embryogenesis. The 
results  suggest  that  Foxi3  regulates  hair  follicle  and  tooth  formation  as  well  as  the  
development of mammary and salivary gland, nail, and eye. Ectodysplasin and 
activin A were identified as upstream regulators of Foxi3.  
Third, Brazilian Terriers with severe skeletal defects at early puppyhood were 
identified through information provided by breeders. Subsequently, a major aim of 
this work was to describe the clinical and pathological features of the syndrome and 
to identify its genetic cause. Clinicopathological examinations and pedigree analysis 
demonstrated that the affected puppies had a recessive spondyloepihyseal dysplasia. 
The disease locus was mapped to chromosome 6 and a mutation leading to 
pathogenic p.P289L change in a conserved functional domain of ?-glucuronidase 
(GUSB) was identified. Elevated glycosaminoglycans were detected in urine and 
only a residual ?-glucuronidase activity was observed in the serum of the affected 
dogs, which confirmed the pathogenity of the mutation. GUSB defects result in 
mucopolysaccharidosis VII (MPS VII) in several species and thus the mutation 
defined the syndrome as MPS VII in Brazilian Terriers.  
Overall, this study illustrates how unique morphological diversity and enriched 
genetic alterations in closed populations can be efficiently harnessed to gain new 
insights into developmental biology across species. For example, the identification 
of the CED mutation in FOXI3 revealed a completely novel gene with a previously 
unknown essential function in ectodermal development. This work has established 
several novel large animal models to further explore disease mechanisms and to 
develop therapeutic methods. Moreover, several new DNA tests have been 
developed for different breeds of dogs to eradicate or, to control better, the 
conditions through improved breeding plans. This will improve the welfare of our 
beloved pets. 
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1 Review of the literature 
Dog, Canis lupus familiaris is considered to be the first domesticated animal. It is 
commonly believed that domestication predates the beginning of agriculture, but the 
more accurate estimate of time and place remains controversial. Based on the fossil 
evidence and phylogenetic findings, canine domestication has been dated to at least 
15,000 years ago, and was followed by the domestication of sheep, goat, cow, pig, 
and others thereafter.  Since domestication, dogs have been selectively bred to form 
the numerous breeds existing today. Modern genetic technology has made it possible 
to  explore  the  evolution  and  origin  of  the  dog  more  accurately  than  using  only  
archeological remains. Well supported evidence suggests that all dog breeds 
originate  from  the  Eurasian  gray  wolf  (Canis lupus lupus) and the latest studies 
indicate South-East Asia to be the initial domestication site, although the results have 
been somewhat controversial when considering the exact geographical location and 
the timing of the process. An initial study using canine mitochondrial DNA 
(mtDNA) that dated the domestication to more than 100,000 years ago [1] has been 
since challenged and more recent mtDNA analyses place the domestication process 
to approximately 16,000 years ago or less [2-4]. On the other hand, some recent 
studies based on archeological and some genetic evidence claim that dogs were 
present already more than 30,000 years ago [5-7]. It is obvious to hypothesize, 
regarding whether domestication occurred once or multiple times, that some 
crossbreeding might have happened during dog evolution. Indeed, this is true at least 
for some North Scandinavian/Finnish spitz breeds for which mtDNA studies indicate 
that a backcrossing of wolf to dog has happened a few hundreds or thousands years 
ago [8].  
The domestic dog population is clearly ancient, although diverse breeds were 
established quite recently since the majority of the breeds are less than 200 years old. 
At the moment, over 400 breeds exist, each defined by specific physical and 
behavioral characteristics, which make the dog the most phenotypically diverse 
domesticated species [9]. Originally different types of dogs arose due to selection for 
behavioral traits for working purposes like hunting or herding and guarding the 
flock. However, the phenotypic variation seen in modern dogs today is mainly a 
result of recent strong artificial selection driven by dog breeders admiring distinctive 
features.  The establishment of registering bodies (e.g. kennel clubs), together with 
breeding standards, has led to a controlled and restricted breeding. Many breeds have 
arisen from a limited number of founder animals and the use of popular sires has 
been common. As a consequence, each breed represents an isolated breeding 
population with high levels of phenotypic homogeneity and, importantly, reduced 
genetic diversity.   
The breed creation process also has had unfavorable consequences producing 
high rates of specific diseases within breeds due to enrichment of the disease causing 
or predisposing alleles. This has happened, first of all, due to random fixation of risk 
alleles during the bottlenecks and use of popular sires harboring the disadvantageous 
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alleles. In addition, some destructive variants have been hitch-hiking along with the 
selected  traits  and  some  undesirable  traits  are  even  due  to  pleiotropic  effects  of  
selected variants, like the dominant mutation causing the dorsal hair ridge in 
Rhodesian and Thai Ridgeback dogs but also predisposing to dermoid sinus [10]. 
 
 
Figure 1.  Creation of modern breeds through domestication (ancient bottlenecks) and breed 
creation (recent bottlenecks). Modified from [11]. 
1.1 Genetic discoveries in dogs benefit human medicine 
Dogs have become an important genetic model organism for numerous heritable 
human diseases, as well as morphological and behavioral phenotypes. A large 
number of successful gene discoveries have confirmed that gene mapping can be 
powerfully performed in dogs. A definite advantage is gained from the canine 
population history which has resulted in the creation of hundreds of breeds, each 
representing an isolated population with breed-specific morphological and 
behavioral characteristics and limited locus and disease heterogeneity [11,12]. On 
the contrary, the genetic heterogeneity is high across different breeds. Dogs possess 
a unique genetic architecture, consisting of short-range linkage disequilibrium (LD) 
and short haplotype blocks resulting from ancient population bottleneck caused by 
the domestication process, in addition to long-range LD and long haplotype blocks 
arising from recent breed creation (Fig. 1) [11,13]. Moreover, artificial selection has 
outweighed the forces of natural selection and as a consequence some parts of the 
genome have undergone a relaxation of selective constraint [14]. Therefore, as dogs 
also have a remarkable phenotypic variation and excess of inherited diseases, they 
offer a unique opportunity for disease gene mapping.  In addition, the dog genome is 
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less divergent from the human than the mouse genome and, therefore, more human 
genomic sequence can be syntenically aligned to the genome of dog than to mouse 
[11]. Dogs have approximately the same number of genes as humans, most of them 
being close orthologues. 
But the canine genetic system offers other advantages as well. Given that most of 
the over 600 genetic disorders that have been described in dogs, have similarities to 
human disease, dogs have emerged as a clinically relevant model of human inherited 
disorders [15]. Dogs serve as a large animal model being both physiologically and 
clinically more similar to human than the mouse. Importantly, dogs used for genetic 
studies are pets that are living in similar environmental conditions along with 
humans  and  are  thus  affected  not  only  by  genetic  traits  but  also  “life  style”.  This  
makes the dog far superior model for human disease than the laboratory mouse that 
lives mostly in pathogen-free and controlled conditions where the outcome or the 
severity of the genetic traits may be stabilized compared to corresponding dog or 
human conditions. A wealth of spontaneously occurring common diseases in dogs 
are analogous to human diseases such as diabetes, cancers, epilepsies, numerous eye 
diseases and autoimmune diseases not to mention high numbers of rare monogenic 
diseases. Heritable diseases, other single locus traits and identified mutations that 
have been demonstrated in dogs are recorded in a public database Online Mendelian 
Inheritance in Animals (OMIA) (http://omia.angis.org.au) [15], which is similar to 
human database Online Mendelian Inheritance in Man (OMIM) 
(http://www.omim.org) [16]. There are 240 mendelian traits or disorders recorded at 
OMIA database and for 165 of those traits the causative mutation has been 
identified. Numbers will be increasing as more and more novel traits and mutations 
are continuously being characterized. Mapping of these disease loci has proven that 
most of the genetic defects underlying the canine diseases are orthologues of the 
corresponding human conditions [17]. 
Moreover, there is well recorded genealogical data available. Purebred dogs have 
long been registered by kennel clubs or other equivalent organizations that record the 
pedigrees, and in some breeds the ancestors can be traced back more than a hundred 
years. The Finnish Kennel Club maintains an open access database of the pedigree 
dogs registrated in Finland. This Breeding Information Database 
(http://jalostus.kennelliitto.fi) contains useful information about each registered 
Finnish dog, e.g. pedigrees and results of health examinations. This can be taken 
advantage of when estimating the mode of inheritance of the phenotype or the 
relationships of the dogs studied. The dogs also have good-quality veterinary 
medical care available. Professional veterinary examinations are essential to achieve 
reliable and detailed diagnosis to help with proper phenotyping. In addition to the 
utility in genetics, the dogs may provide useful models for the development and 
validation of novel therapies for diseases. This has been verified in dogs with X-
linked ectodermal dysplasia mutation of ectodysplasin (Eda); a single neonatal 
treatment with recombinant EDA prevents the respiratory disease in dogs [18,19]. At 
the moment, clinical trials with human patients having the similar X-linked mutation 
and ectodermal dysplasia are ongoing. 
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1.1.1 Genomic resources and methods for trait mapping in dogs 
Interest  in  canine  genetics  has  boomed  after  the  sequencing  and  annotation  of  its  
genome. The first draft of dog genome was published in 2003 but containing only 
1.5x whole-genome sequence of a Standard Poodle [20]. This was followed by a 
high quality version (7.5x) of a Boxer genome, CanFam1.0, and soon after an 
updated assembly CanFam2.0 [11]. These genomes revealed millions of single 
nucleotide polymorphisms (SNPs) that have been utilized in gene mapping studies 
thereafter. The newest genome build, CanFam3.1, was released in 2012. The dog 
genome, divided in 39 chromosomes, consists of approximately 2.4 Gb of nucleotide 
sequence and approximately 19,900 coding genes [11]. 
Traditional genome-wide association studies (GWAS), using unrelated cases and 
controls from the same population, have been extremely successful in identifying 
monogenic diseases in dogs. The first genome-wide SNP genotyping arrays from 
Affymetrix and Illumina contained less than 30,000 SNPs and were followed by the 
generation of higher density arrays, 50K Affymetrix array and the present high-
density 172K Illumina array. From these, the 22K Illumina array and 50K 
Affymetrix array were used in this study.   
Many of the phenotypic traits in dogs are fixed breed characteristics in particular 
breeds and, thus, classical genome-wide association analysis using cases and 
controls from the same breed cannot be applied for mapping these traits. An 
alternative approach is to perform GWAS by an across breed mapping, utilizing 
long-range LD blocks. The present 172K Illumina genotyping array has high SNP 
density, which enables a genomic survey with moderate resolution for copy number 
variants (CNVs) and for selective sweeps characterized by long regions of reduced 
heterozygosity [21]. 
Novel genetic methods utilizing next generation seguencing (NGS) technology 
such as targeted sequence capture, exome sequencing, transcriptome sequencing, 
mtDNA sequencing, and whole genome resequencing are becoming more and more 
routine and enable more efficient analyses with higher resolution data. Moreover, a 
recent release of the third draft of canine genome sequence CanFam 3.1 with 
improved sequence quality and annotation will likely facilitate the analysis of NGS 
data.   
1.2 Developmental variation and defects in dogs  
As a result of artificial selection, numerous morphological and behavioral 
characteristics have been enriched in breeds and even fixed as breed characteristics. 
This has led to a vast amount of morphological variation, which is greater than in 
any other species. Morphological features are formed during embryonic 
development and thus these characteristics offer a model for studying the genetic 
regulation of developmentally important molecular determinants. A growing number 
of genetic factors controlling the formation of canine morphological traits, such as 
body size, leg length and skull shape, have been characterized. Insulin-like growth 
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factor 1 (IGF1) and IGF1 receptor (IGF1R) have been indicated to be associated 
with canine body size [22,23]. These studies suggest that IGF1 pathway has major 
effect on controlling the size variation in dogs. Disproportionate dwarfism or 
chondrodysplasia is a distinguishable feature in numerous breeds such as 
Dachshund, Basset Hound, and Pembroke Welsh Corgi. Multibreed approach with 
GWAS across more than 70 breeds revealed a strong association on chromosome 18 
(CFA18) and revealed an insertion of an extra functional copy of fibroblast  growth 
factor 4 (FGF4) gene as the cause [24]. A mild recessive form of disproportionate 
dwarfism in Labrador Retrievers designated as skeletal dysplasia 2 was recently 
described and indicated to be caused by a mutation in collagen alpha-2(XI) chain 
(COL11A2) gene [25]. Abnormal growth of craniofacial bones leads to 
brachycephaly in Boxers, Bulldogs, and numerous other short muzzled breeds. This 
polygenic trait has been mapped to chromosome 1 but numerous other loci in several 
chromosomes have as well been described [17,26,27]. Fine-mapping of one of these 
loci locating in CFA32 revealed a mutation at highly conserved position of bone 
morphogenetic protein 3 (BMP3) [27]. Genes affecting the dog coat growth pattern, 
length, and curl were explored by GWAS using more than 1,000 dogs from 80 
different breeds. As a result, mutations in three genes, R-spondin-2 (RSPO2), 
fibroblast  growth  factor  5  (FGF5) and keratin-71 (KRT71) were shown to explain 
more than 95% of the canine coat variation [28].  
The following chapters will focus on the subjects of this thesis, including three 
inherited canine developmental defects: caudal dysplasia, ectodermal dysplasia, and 
mucopolysaccharidosis VII. 
1.2.1 Caudal dysplasia  
Caudal dysplasia, also referred to as caudal regression and sacral agenesis syndrome, 
is a rare (1-2.5/100,000 births) congenital malformation in human characterized by 
varying degrees of developmental failure of posterior body in early embryogenesis. 
It involves the lower extremities, the lumbar and coccygeal vertebrae, and 
corresponding segments of the spinal cord and sometimes major visceral anomalies. 
The etiology is unclear but maternal diabetes, genetic factors, and vascular 
hypoperfusion have been suggested to contribute. It has been hypothesized that T, 
brachyury homolog (mouse) (T) might be involved in sacral agenesis or congenital 
vertebral malformations in human patients but definitive evidence is lacking. A 
heterozygous c.1013C>T variant was found to be significantly associated in three 
unrelated patients with congenital vertebral malformations [29]. A clinically 
unaffected parent of each patient, however, also harboured the same variant. Earlier 
genetic studies have indicated that T gene is highly polymorphic. Several studies 
have identified non-synonymous variants in T, some implicating association with 
susceptibility to neural tube defects, whereas some excluding it. Another study also 
has excluded T locus as a major contributor for sacral agenesis [30-33].  
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1.2.1.1 Caudal dysplasia and tail length in dogs 
Several dog breeds show very short tails (brachyury) or even complete absence of 
the tail vertebrae (anury). The dominant inherited trait is characterized by short tail, 
varying from a complete tailless to a half a tail with occasional kinks. A genetic 
cause of this dominant short-tail phenotype was originally identified in Pembroke 
Welsh Corgis [34]. The study demonstrated a c.189C>G mutation in exon 1 of the T 
gene that was shown to affect the DNA-binding property of the T protein and result 
in the bobtail phenotype in heterozygote animals. Embryonic lethality of the 
homozygous mutation was suggested as there were no dogs homozygous for the 
mutation found among the offspring of short-tailed parents. However, another study 
reported two malformed Welsh Corgi Pembroke puppies born to short-tailed parents 
and they were genotyped as homozygous for the T c.189C>G mutation [35]. One of 
the puppies was stillborn but the other stayed alive until put to death at one day old. 
The puppies had anorectal atresia and multiple serious spinal malformations. The 
study demonstrated that puppies homozygous for the T mutation can be born alive 
although it has been suggested that majority of the homozygote animals die early in 
fetal development. The phenotype of these homozygous dogs resembles human 
caudal dysplasia or caudal regression syndrome. Examination of 19 short-tailed 
Pembroke Welsh Corgi dogs showed no other spinal abnormalities than short tail 
[35] unlike heterozygous mice that have shown to manifest additional spinal defects 
[36,37].  
There are several breeds with natural short-tailed dogs and also with variable 
phenotype and inheritance such as likely recessively inherited type of short tail in 
English and French Bulldogs, where all dogs in the breed have so called screw tail, 
short tail with multiple kinks. There are also occasionally short-tailed dogs born for 
long-tailed parents in some breeds, suggesting multiple patterns of inheritance or 
variations in penetrance. These dogs could serve as a model to explore the genetics 
of posterior vertebral development and caudal dysplasias in humans. 
1.2.1.2 T gene 
T encodes for a transcription factor containing the DNA-binding domain called T-
box which is highly conserved among different metazoan species and defines the 
family of T-box genes. The members of T-box gene family have essential function in 
many developmental processes of both vertebrate and invertebrate embryos, like 
specification of the primary germ layers (ectoderm, mesoderm and endoderm) during 
gastrulation and assignment of cell identities in organogenesis. They have also been 
associated with several diseases in human: e.g. Holt-Oram syndrome, characterized 
by upper limb and cardiac malformations, is caused by mutations in T-box 5 (TBX5), 
while mutations in T-box 3 (TBX3) causes ulnar-mammary syndrome [38-40].  
Mouse Brachyury (T) has an important function during early embryonic 
development being a key regulator of mesoderm formation [36,41-44]. T is needed 
for the correct specification of mesodermal identity in the epiblast during 
gastrulation and specification and cell survival in the notochord. In addition, it is 
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required for the development of the derivatives of posterior mesoderm including 
posterior somites and allantois. Mutations in T cause early embryonic lethality as 
homozygous. Defected T function results in abnormalities in the development of 
mesodermal tissues, including the tail and spine, thus suggesting an essential role for 
the T in mouse development [42]. In mice, T starts to be expressed at the onset of 
gastrulation in the nascent mesoderm at the primitive streak. As gastrulation 
proceeds, expression can be seen in the ectoderm next to the streak and in the newly 
formed mesoderm [41,45]. The expression is soonafter downregulated in the 
mesoderm when it separates into layers of paraxial and lateral plate mesoderm. 
Instead, T continues to be expressed in the mesoderm of the tailbud until embryonic 
day (E) 12.5-13.0. Tailbud is a structure which the posterior axis, namely lumbar, 
sacral and caudal vertebrae, is derived from [46]. In addition, the notochord 
precursor cells start to express T and the expression persists later in the notochord 
and its derivatives [41,45].  
There are tens of T mutant-mouse lines; both spontaneous, chemically and 
radiation induced and genetically modified. The earliest phenotype caused by 
spontaneous mutation was already described in 1927 by Dobrovolskïa-Zavadskaïa 
[47], who reported the heterozygous mutant mice having a short and often kinked 
tail. Later it was shown that the homozygous animals had severe abnormalities in the 
development of posterior mesodermal organs leading to posterior truncation. The 
mice had thickened primitive streak, absent or abnormal somites posterior to somite 
7, and absent notochord [36,48,49]. The embryos died at approximately 10.5 dpc 
(days post-coitum) due to the failure of the allantois to extend and connect with the 
placenta [50]. Recently, it has been demonstrated that inducible miRNA-based in 
vivo knockdown of T results in hypomorphic phenotype and causes axial skeletal 
defects and urorectal malformations resembling human caudal regression syndrome 
[51]. 
1.2.2 Ectodermal dysplasia 
Human ectodermal dysplasias are a large group of congenital syndromes 
characterized by the abnormal development of two or more ectodermal appendages, 
teeth and hair follicles being the most commonly affected organs. The patients 
typically have sparse hair, absence of several deciduous and permanent teeth and 
diminished sweating. The remaining hair follicles are dysplastic, teeth are abnormal, 
and defects in various exocrine glands and nails are common. In addition, the typical 
features can occasionally be accompanied by various other dysmorphic features such 
as cleft lip or palate, limb dysplasia, or immunological aberrations and mental 
retardation. The most common form of ectodermal dysplasia in human is the X-
linked hypohidrotic ectodermal dysplasia (HED) (OMIM #305100), which is caused 
by a mutation in ectodysplasin (EDA) gene. Autosomal dominant and recessive 
forms of HED are mostly results of mutations in other genes of the ectodysplasin 
signaling pathway, ectodysplasin A receptor (EDAR; OMIM #129490 and #224900), 
and intracellular adaptor protein EDAR-associated death domain (EDARADD; 
OMIM #614940 and #614941). 
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1.2.2.1 Canine ectodermal dysplasia 
The three hairless breeds recognized by Fédération Cynologique Internationale (FCI) 
are  Chinese  Crested,  Mexican  Hairless  and  Peruvian  Hairless  dogs.  The  history  of  
these hairless dogs dates back to more than 3,000 years ago, since statues looking 
identical to the Mexican Hairless dog (“Xoloitzcuintle”) have been found in tombs 
of  the  Mayan,  Colima  and  Aztec  Indians.  These  dogs  were  raised  by  the  native  
people and were considered sacred but are thought to have also been bred for their 
meat. Hairless dogs were described as Canis aegyptius by Linné [52] and also 
Darwin referred to the Turkish naked dog with defective teeth [53]. The Peruvian 
and Mexican Hairless dogs have also been used to relieve rheumatism throughout 
history (Fig. 2). 
 
Figure 2. California State Journal of Medicine advertised Mexican Hairless dog as “sure cure 
for rheumatism” in 1919 [54]. 
The hairless breeds are representatives of dogs with a phenotype considered as a 
breed characteristic that could be medically classified as a disease, ectodermal 
dysplasia. These dogs have missing or abnormally shaped teeth and absent or very 
sparse body hair with a variable amount and length of coat on top of the head, the 
toes,  and  the  tip  of  the  tail.   Chinese  Crested  dogs,  in  particular,  have  a  very  
characteristic appearance with long coat on these areas. Canine ectodermal dysplasia 
(CED) is inherited as a monogenic autosomal semidominant trait, since heterozygous 
dogs show the characteristic phenotype but homozygous mutants apparently die 
during embryogenesis [55]. 
Fukuta et al. [56] studied histologically skin and lymphoid organs of dogs 
derived from the Mexican Hairless breed. They demonstrated that the skin of 
newborn puppies comprised a thick epidermis with rudimental hair follicles but dogs 
older than 2 months of age had thin epidermis with only few epidermal ingrowths 
and no hair follicles or skin glands except in the hairy parts of the skin. The thymus 
of the newborn hairless puppies was normal but it had atrophied in older dogs, and 
lymphocyte  accumulation  was  poor  in  the  thymus  as  well  as  in  the  spleen  and  
mesenteric lymph nodes [56].  
A recent article reported a detailed histological analysis of the hair follicles and 
glandular organs of Chinese Crested dogs [57].  The dogs with forkhead box I3 
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(FOXI3) mutation had only simple primary hair follicles compared to the compound 
follicles of genotypically normal dogs. However, apocrine glands in the skin 
(sebaceous and sweat glands), respiratory mucous glands, nictitating membrane and 
the mammary gland were demonstrated to have no macroscopic or histopathological 
abnormalities [57]. 
Due to phenotypic similarity to HED, the possible involvement of candidate gene 
EDAR has been studied but excluded as causative gene [58]. CED was mapped by 
linkage analysis to canine chromosome 17 (CFA 17) in Chinese Crested Dogs [59].  
1.2.2.2 Other canine ectodermal dysplasias 
Canine X-linked HED has been clinically characterized in many breeds [60,61]. 
Similar to humans, a mutation in EDA was identified to cause the disease in a colony 
of dogs [62]. Canine X-linked HED is also clinically similar to the human disease. 
The clinical features include varying degrees of alopecia, oligodontia, abnormally 
shaped teeth and absence of certain exocrine glands, such as sweat and sebaceous 
glands. Affected dogs are also susceptible to pulmonary infectious diseases likely 
due to lack of tracheal and bronchial glands resulting in decreased mucociliary 
clearance.  
Another ectodermal dysplasia type of disorder reported in dogs is an ectodermal 
dysplasia-skin fragility syndrome, which is a hereditary skin adhesion disorder 
belonging to the group of epidermolysis bullosa diseases. There is a clinically 
analogous disease in humans. In addition to the manifestations of the disease 
associated with the skin fragility arising from epidermal cell-cell separation 
(acantholysis), all human patients have been reported also to have hair abnormalities 
such as partial hypotrichosis to complete hairlessness, woolly hair, as well as nail 
dystrophies [63]. Recently, ectodermal dysplasia-skin fragility syndrome was 
demonstrated to also be genetically analogous to the human syndrome when 
plakophilin-1 (PKP1) deficiency was described in affected Chesapeake Bay 
Retriever dogs [64]. Candidate gene sequencing revealed a homozygous splice donor 
site mutation within the first intron of PKP1 resulting in a premature stop codon as 
causative for this autosomal recessive disease. 
1.2.2.3 Development of ectodermal organs 
Skin appendages such as teeth, hairs, nails and many glands are all derivatives of the 
embryonic ectoderm. Although these mature fully-developed organs are highly 
divergent in shape and function, their early development is notably similar, both at 
the morphogenetic and molecular levels. The organogenesis of the ectodermal 
organs is regulated by interactions between ectodermal epithelium and mesenchyme 
that originates either from the mesoderm (e.g. in  the  case  of  body  hairs  and  
mammary gland) or from the neural crest (in the case of teeth and cranial hairs). The 
organ development can be divided into three stages: initiation, morphogenesis and 
cell differentiation. The initiation of appendage development is seen as a local 
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epithelial thickening, called the placode, which invaginates into the underlying 
condensating mesenchyme and forms an epithelial bud (Fig. 3). In mice, incisor and 
first molar placodes appear at embryonic day 12 (E12), the first set of hair placodes 
at E14 and mammary placodes at E11-E11.5 [65,66].  
 
 
Figure 3. Development of ectodermal organs. The beginning of the development of different 
ectodermal organs is very similar. Epithelium thickens forming a placode and 
mesenchyme starts to condense around it. Subsequently, the placode grows 
forming a bud which invades into the underlying mesenchyme. Tightly controlled 
growth and branching of the epithelium and mesenchyme during morphogenesis 
determines the final shape of each specific organ. Modified from and used with 
permission [67]. 
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In the following step, the epithelial bud grows and folds and as a consequence an 
organ specific shape is formed. Subsequently, the anatomical differences of the 
various ectodermal organs become more evident. The tooth epithelium grows 
extensively and undergoes complex folding morphogenesis through cap (at E14 in 
mouse) and bell (E16) stages. Consequently, the cusp morphology specific for each 
tooth type and later constituting the future tooth crown, is formed [68]. Distinct 
morphogenesis  of  the  hair  includes  elongation  of  the  hair  germ and  formation  of  a  
peg. 
Tightly controlled reciprocal interactions between different tissue types regulate 
the formation of ectodermal appendage development. This crosstalk  involve several 
families of signaling molecules the most essential being wingless-type MMTV 
integration site family (Wnt), transforming growth factor ? (TGFb) (such as bone 
morphogenetic factors (BMPs) and activins), fibroblast growth factor (FGF), 
hedgehog (HH) and tumor necrosis factor (TNF) families [69,70]. Their functions 
are widely conserved between species and also between ectodermal appendages [66]. 
Consequently, mutations in several genes lead to defects in more than one 
ectodermal organ type. Signaling molecule Eda belongs to the family of TNF’s and 
signals through its receptor Edar. Eda/Edar signaling pathway has a crucial role in 
the development of tooth and hair follicle [18,71]. Spontaneous Eda-deficient mice 
have missing and abnormally shaped teeth, and lack primary hair placodes [72], 
whereas overexpression of Eda in epithelium results in enlarged hair and/or ectopic 
hair, tooth and mammary placodes [73,74]. Eda is a key regulator of ectodermal 
development as the targets of Eda/Edar signaling pathway include several other 
important molecules such as BMP antagonists Ccn2/ctgf and follistatin, Fgf20, Dkk4 
and Shh [75]. BMPs, especially BMP4, have inhibitory function for placode 
formation and are expressed exquisitely in interfollicular region [76]. Several FGFs 
are expressed in epithelial compartments and signal to mesenchyme. For example 
Fgf3, Fgf4, Fgf9, Fgf15 and Fgf20 are expressed in tooth placode and/or enamel 
knot during tooth formation [77-80]. Activin A is a homodimer composed of two 
subunits encoded by inhibin ?A (Inhba). Inhba is expressed in the condensed 
mesenchyme in developing hair follicles and teeth, but epithelium is thought to be 
the target tissue [81,82]. Loss of Inhba leads to a developmental arrest of incisors 
and mandibular molars at the bud stage [81], and K14-Cre mediated conditional 
deletion of activin receptor 1b causes various degrees of hairlessness [83]. Wnt/ ?-
catenin signaling pathway is essential for the development of all skin appendages. 
Forced activation of this pathway in ?-cat?ex3K14/+ embryos causes formation of 
supernumerary enamel knot signaling centers leading to continuous tooth generation, 
as well as precocious and ectopic hair follicle development [84,85]. Moreover, 
elevated Wnt/?-catenin signaling activity in Sostdc1-deficient mice result in extra 
incisors, premolar like teeth, enlarged hair placodes, and ectopic whisker buds [86-
89]. 
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1.2.2.4 Forkhead family of transcription factors  
FOX proteins form a large family of fox transcriptional regulators characterized by 
an evolutionarily conserved DNA-binding domain (forkhead domain). FOX proteins 
have diverse functions ranging from embryonic development to regulation of 
metabolic processes and the immune system in the adult organism [90].  
Ohyama and Groves [91] analyzed the expression of mouse Foxi3 during early 
embryonic development from E6.5 to E10.5 and demonstrated that the expression 
covers the surface ectoderm adjacent to the neural plate, called panplacodal 
primordium, from late E6.5 to presomite stages. The panplacodal primordium is the 
origin for all cranial placodes giving rise to various sensory ganglia and contributing 
to the function of sensory organs and the pituitary gland [92]. Subsequently, during 
early somite stages, Foxi3 expression is downregulated from the ectoderm and 
becomes restricted to branchial arches and later at E9.5 to E10.5 specifically to the 
region between maxilla and mandible and branchial pouches. Foxi3 was shown to be 
expressed also in the dorsal part of the optic cup from E9.5 to E10.5. A very similar 
pattern of Foxi3 expression was recently demonstrated in chicken [93]. Based on the 
early embryonic expression pattern it has been suggested that Foxi3 is important in 
the establishment of the panplacodal domain and branchial pouch development [91].  
1.2.3 Mucopolysaccharidoses 
Deficiencies of lysosomal enzymes involved in the degradation of 
glycosaminoglycans (GAGs) cause a group of lysosomal storage diseases called 
mucopolysaccharidoses (MPSs). GAGs such as chondroitin, dermatan, heparan and 
keratin sulfates as well as hyalyronic acid, are long unbranched sulfated 
carbohydrates with repeating disaccharide units. While these heteropolysaccharides 
are synthetized they, with the exception of hyalyronic acid, are covalently attached 
to a specific protein core to produce molecules called proteoglycans (Fig. 4). 
Subsequently, proteoglycans are secreted forming a major component of the 
extracellular matrix. Proteoglycans are abundant in many tissues and have variety of 
functions being important for example in many developmental processes and tissue 
repair [94]. Many proteoglycans are structural, such as aggrecan that is a major 
proteoglycan in cartilage. In addition, they can control enzymatic activities and some 
even function as cell surface receptors. Heparan sulfate proteoglycans (HSPGs) have 
been extenxively studied in invertebrate and vertebrate development. A large number 
of growth factors, e.g. FGFs, Wnts and HHs, can bind HSPGs which serves as a way 
to concentrate ligands at the cell surface [95]. Heparan sulfates are essential in 
regulating the formation of morphogen gradients that are crucial in many 
differentiation events [96]. One family of HSPGs, namely syndecans, serves as 
transmembrane receptors which are able to transmit signals independently or 
together with other receptors [94]. 
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Figure 4. Structure of proteoglycans. The GAGs are covalently attached to core proteins at 
regular spaces and extend perpendicularly from the core forming a brush-like 
structure. Aggrecan, a major component of articular cartilage, is composed of large 
proteoglycan structures that are connected to a polysaccharide backbone, 
hyalyronic acid, via link proteins. The figure is used with permission [98]. 
 
Figure 5. Degradation pathway of glycosaminoglycans. The stepwise degaradation of 
heparan and dermatan sulfate, and other GAGs, requires a cascade of enzymatic 
activity. Enzyme names are shown in green and the disorders caused by defective 
enzyme activity in blue. Modified and reproduced with permission of 
themedicalbiochemistrypage.org, LLC.    
Depending on the GAG in question, one of the four different pathways is 
responsible for the degradation of these carbohydrate polymers: chondroitin sulfate, 
dermatan sulfate, heparan sulfate, or keratan sulfate degradation pathway. In each 
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pathway, several different lysosomal enzymes are required for the stepwise 
degradation  of  GAGs  (Fig.  5).  Deficiencies  of  these  enzymes  cause  MPSs  which  
have been categorized into eleven different forms in humans based on the underlying 
enzyme deficiency (Table 1) [97]. 
 
Table 1.  Summary table of different types of mucopolysaccharidoses 
Type Alternative 
name 
Deficient 
gene 
symbol 
Deficient enzyme OMIM Dog model 
MPS I Hurler, 
Scheie 
IDUA ?-L-iduronidase 607015 Plott Hound [99], 
Rottweiler, Boston Terrier 
[100] 
MPS II Hunter IDS Iduronate 2-sulfatase 309900 Labrador Retriever* [101] 
MPS 
IIIA 
Sanfilippo 
type A 
SGSH Heparan sulfate 
sulfamidase 
252900 Dachshund [102], 
Huntaway Dog [103] 
MPS 
IIIB 
Sanfilippo 
type B 
NAGLU ?-N-
acetylglucosaminidase 
252920 Schipperke [104] 
MPS 
IIIC 
Sanfilippo 
type C 
HGSNAT Acetyl-CoA 
transferase 
252930 None 
MPS 
IIID 
Sanfilippo 
type D 
GNS N-acetylglucosamine 
6-sulfatase 
252940 None 
MPS 
IVA 
Morquio 
type A 
GALNS Galactose 6-sulfatase 253000 None 
MPS 
IVB 
Morquio 
type B 
GLB1 ?-Galactosidase 253010 None 
MPS 
VI 
Maroteaux-
Lamy 
ARSB Arylsulfatase B (N-
acetylgalactosamine 
4-sulfatase) 
253200 Miniature Pinscher [105], 
Miniature Poodle-type dog 
[106] 
MPS 
VII 
Sly GUSB ?-glucuronidase 253220 mixed breed [107], German 
Shepherd [108] 
MPS 
IX 
 HYAL1 Hyalyronidase 601492 None 
*Not genetically identified but based on clinical diagnosis only 
Due to deficient degradation of GAGs the characteristic feature of the MPSs is 
the accumulation of GAGs in lysosomes of various cell types such as fibroblasts, 
macrophages, leukocytes, chondrocytes and parenchymal cells of the liver. The 
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undegraded GAGs are also excessively excreted into urine.  The excessive GAG 
accumulation leads to developmental disturbancies and dysfunction of many tissues 
and organs. Clinical characteristics of these progressive disorders are various and 
differ between MPS types but they also share features such as dwarfism, 
undeveloped epiphyseal centers, dysostosis multiplex, facial dysmorphia, corneal 
clouding and organomegaly [97]. Several MPS types have been identified clinically 
and  genetically  in  dogs  as  well  (Table  1).  As  in  humans,  all  are  inherited  as  
autosomal recessive traits, except MPS II, which is X-linked.  
1.2.3.1 Mucopolysaccharidosis VII 
MPS VII (also referred to as Sly syndrome in human) is caused by deficient 
activity of ?-glucuronidase (GUSB) enzyme leading to lysosomal accumulation of 
glucuronic acid containing GAGs (heparan, dermatan, chondroitin 4- and 
chondroitin 6-sulfates) [109]. GUSB mutations have been described in multiple 
species including human, mouse, cat, and dog.  
Disease characteristics in human patients (OMIM #253220) include: mental 
retardation, skeletal deformities (dysostosis multiplex), corneal clouding, and 
hepatosplenomegaly. The clinical variability among human is extensive ranging 
from prenatal lethality to mild skeletal abnormalities with normal intelligence. The 
skeletal involvement is an early and prominent feature in almost all MPS disorders 
and leads to dysplastic skeletal features and short stature. The human GUSB gene 
contains 12 exons and encodes a 651-amino acid precursor. The precursor of GUSB 
undergoes cleavage and glycosylation and is transported into the lysosomes where its 
subunits form the mature enzyme [110].  
Almost 50 unique mutations in GUSB have been described in human. The site of 
the mutation in the GUSB gene correlates with the residual enzymatic activity and 
related clinical severity [111]. It has been demonstrated that even a small percentage 
of normal GUSB activity (2-3%) can protect against a severe phenotype. 
Seven spontaneous or induced murine MPS VII models are available [112-116]. 
All models present similar clinical, morphological, and histopathological 
characteristics but the severity of the deficits depends on the strain. The phenotypical 
features in mice are comparable with human MPS VII patients, including shortened 
life-span, dysmorphic facial features, skeletal dysplasia, and widespread lysosomal 
storage of GAGs in various tissues.  
GUSB deficiency has been described in three separate cases of cats as well, but 
the causative mutation has been identified only in one of them [117-119]. All three 
feline models share typical clinical signs of MPS VII including a young age of onset, 
dwarfism, facial dysmorphism, walking difficulties, corneal clouding, epiphyseal 
dysplasia of the vertebrae and long bones, and vacuolization in several tissues. The 
causative mutation has been identified in one population of cats; p.E351K 
substitution affects a highly conserved residue of GUSB [119]. 
Canine MPS VII has been previously identified in two cases, in a mixed breed 
dog and a German Shepherd, having identical missense mutation, resulting in 
p.R166H substitution [107,108,120].  The first symptoms in these dogs appeared at 2 
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to 5 months of age and involved weakness of the hind legs followed by a progressive 
dysfunction  of  all  limbs.  The  affected  dogs  also  presented  other  typical  MPS  VII  
features including growth retardation, facial and skeletal dysmorphisms, and corneal 
clouding. Joints were extremely lax and easily subluxated, and radiographic 
examination showed severe epiphyseal dysplasia. Abnormalities in several other 
organs were also present, including hepatomegaly, tracheal dysplasia, and cardiac 
abnormalities.  
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2 Aims of the study 
The  overall  objective  of  this  study  was  to  identify  the  genetic  causes  of  three  
congenital developmental defects in dogs. Gene discoveries would then pave the 
way for further functional studies and pathway characterization and would help to 
develop new genetic tests for breeding purposes and aid in clarifying the etiology of 
corresponding conditions in humans. The specific aims of the study were the 
following: 
 
1. To clarify the genetic cause of short tail in various short-tail breeds, starting 
from the known T gene mutation and extending the analyses to the whole 
coding region of the gene, if necessary (I).  
 
2. To explore the eventual genetic heterogeneity behind the common short-tail 
phenotype to better understand development of caudal dysplasia (I). 
 
3. To identify a causative mutation for canine ectodermal dysplasia in three 
hairless breeds (II) 
 
4. To characterize the function of the novel ectodermal dysplasia gene in 
ectodermal organ development and identify its upstream regulators (III) 
 
5. To describe the clinical and pathological features of the skeletal syndrome in 
Brazilian Terriers and to identify its genetic cause (IV) 
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3 Materials and methods 
3.1 Study cohorts, pedigrees (I, II, IV)  
Dr. Lohi’s research group has established a large dog DNA bank in Finland currently 
including DNA samples of more than 40,000 dogs from 250 breeds. All samples 
used in these studies have been collected from privately owned pets. This significant 
resource has been used in all studies presented here. A large number of canine 
samples were also collected by the collaborators in Switzerland and France. 
In Study I, the initial cohort consisted of 360 dogs from 23 breeds. Among these 
were 156 short-tailed and 204 long-tailed dogs. In addition, samples were collected 
from 80 dogs encompassing 9 breeds presenting only the long-tail phenotype. 
Pedigrees and tail phenotype information were collected from each sampled dogs. 
Tail phenotypes were recorded by the sample collector, the owner or from the public 
dog registry of the Finnish Kennel Club (http://jalostus.kennelliitto.fi). 
In Study II, samples from altogether 195 partially related dogs were used (93 
hairless and 49 coated Chinese Crested dogs, 39 hairless and 6 coated Peruvian 
Hairless  dogs  and  8  hairless  Mexican  Hairless  dogs).  From  these,  GWAS  was  
performed using samples from 20 hairless and 19 coated Chinese Crested dogs, the 
rest were included in the fine-mapping.  
In Study IV, samples were collected from a total of 202 Brazilian Terriers 
including 15 affected puppies from eight litters and 187 healthy controls. A large 
pedigree was established around the affected dogs using the GenoPro genealogy 
software (http://www.genopro.com/) and utilizing the public dog registry of the 
Finnish Kennel Club (http://jalostus.kennelliitto.fi) to evaluate the modes of 
inheritance.  
Study I was conducted in collaboration with the research groups of Catherine 
André and Francis Galibert at the University of Rennes, France, the genetic testing 
laboratory Antagene, France and Lars Paulin at the Institute of Biotechnology, 
University of Helsinki. Study II was conducted in collaboration with the research 
groups of Tosso Leeb at the University of Bern, Switzerland and Kerstin Lindblad-
Toh at the Broad Institute of Harvard and Massachusetts Institute of Technology, 
USA and at the Uppsala University, Sweden. Study III was conducted in 
collaboration  with  the  research  groups  of  Marja  Mikkola  and  Irma Thesleff  and  at  
the  Institute  of  Biotechnology,  University  of  Helsinki  and  Tosso  Leeb  at  the  
University of Bern,  Switzerland. Study IV was conducted in collaboration with the 
veterinarians at the Animal Hospital of University of Helsinki (Anu Lappalainen, 
Heli Kallio and Marjatta Snellman).  
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3.2 Genomic DNA extraction (I, II, IV) 
Samples were either ethylenediaminetetra-acetic acid (EDTA) -blood or buccal cell 
samples. Samples were collected either by a trained representative of the research 
laboratory or a licensed veterinarian. In Study I, samples were collected in Finland 
and by the collaborators in France. In Study II, samples were collected in Finland 
and by the collaborators in Switzerland. In Study IV, all samples were collected in 
Finland.  Blood  samples  were  stored  at  -20°C  until  genomic  DNA  was  extracted.   
Genomic DNA was extracted from blood samples for Study I using Puregene DNA 
Purification Kit (Gentra Systems, Minneapolis, MN). Blood and buccal cells for 
Study I were extracted using either the NucleoSpin Kit (Macherey-Nagel, Hoerdt, 
France) or the BuccalAmp DNA Extraction Kit (Epicentre Biotechnologies, 
Madison, WI). Some samples with low DNA yields were amplified using the V2 
Genomiphi Kit (GE Healthcare, Buckinghamshire, UK). DNA concentration was 
determined with the NanoDrop-1000 UV/Vis Spectrophotometer (NanoDrop 
Technologies, Wilmington, DE).  
Collection of blood samples was approved by the Animal Ethics Committee at 
the State Provincial Office of Southern Finland (ESLH-2009-07827/Ym-23). Owner 
consent was collected for each dog. 
3.3 PCR and sequencing (I, II, IV) 
PCR reactions  were  carried  out  in  using  a  standard  PCR protocol  or  in  the  case  of  
GC-rich amplicons the Advantage GC Genomic LA Polymerase Mix (Clontech 
Laboratories, Inc., Mountain View, CA). The details of the primers used in studies I, 
II and IV have been described in the “Materials and Methods” section of each 
publication.  
In Study I, the presence of the T mutation  in  the  amplified  PCR  product  was  
detected either by restriction enzyme assay with BstEII enzyme (New England 
Biolabs, Ipswich, MA) or sequencing.  
PCR products were cleaned by ExoSAP-IT (GE Healthcare) and sequenced with 
either ABI PRISM 3130XL or 3730XL DNA Analyzer (Applied Biosystems, Foster 
City, CA). The resulting sequencing data were analyzed using either Sequencher 4.6 
(Gene Codes Corporation, Ann Arbor, MI), Variant Reporter v1.0 or DNA 
Sequencing Analysis v5.2 software (Applied Biosystems, Foster City, CA). 
Fragment size analyses were performed with the GeneMapper 4.0 software (Applied 
Biosystems, Foster City, CA). 
3.4 Reference sequence and SNP databases (II and IV) 
The dog genome build CanFam2.0 and human genome build 36 were used as 
references. The canine SNP databases are provided by the Broad Institute and are 
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available online: SNPs mapped on CanFam1.0 
(http://www.broad.mit.edu/mammals/dog/snp) and CanFam2.0 
(http://www.broad.mit.edu/mammals/dog/snp2). 
3.5 Statistical analysis (I) 
The possible effect of the homozygous T gene mutation for embryonic viability was 
estimated by following the litter sizes of short-tailed parents compared with long-
tailed parents in Swedish Vallhund breed. Statistical significance of the variation 
between the study groups was measured by Student’s t-test. 
3.6 Genome wide association study (II and IV) 
Study II: Samples (20 hairless and 19 coated Chinese Crested dogs) were genotyped 
using  the  50K  canine  Affymetrix  v2  SNP  array  (Affymetrix,  Santa  Clara,  CA).  
Association analysis was performed by free, open-source analysis toolset PLINK 
(http://pngu.mgh.harvard.edu/purcell/plink/) [121]. Only the 49,663 SNPs were 
included. SNPs with a genotyping rate less than 95% (9,730) were removed. 
Subsequently, the average genotyping rate per individual was 94.23%. Genotype 
data were further filtered with minor allele frequency (MAF) >20%, as the causative 
mutation must occur once in each affected dog. Based on this 34,175 SNPs were 
removed from the analysis. 12,355 SNPs remained for analyses after frequency and 
genotype pruning. Genome-wide significance was ascertained with permutation 
testing (n = 10,000). In order to analyze the haplotype association, the haplotype 
frequencies were determined for each set of 2-8 SNPs across the genome using 
PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) [121], and the logarithm of odds 
(LOD) score was calculated using the Haplotype Likelihood Ratio test [11].  
In Study IV, the samples (seven cases and eleven controls) were genotyped using 
Illumina’s CanineSNP20 BeadChip of 22,362 validated SNPs. Case-control 
association analysis was performed by PLINK 
(http://pngu.mgh.harvard.edu/purcell/plink/) [121]. Genotype data were filtered with 
a SNP call rate of >95% and MAF of >5%. Based on these criteria 366 SNPs were 
removed for low genotyping efficiency and 5,647 SNPs for low MAF. No individual 
dogs were removed for low genotyping and no SNPs were removed because of 
significant deviations from the Hardy-Weinberg equilibrium (p ? 0.0001). After 
frequency and genotype pruning, 16,595 SNPs remained for analyses. Genome-wide 
significance was ascertained with phenotype permutation testing (n = 10,000).  
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3.7 Fine-mapping (II) 
A total of 111 SNPs located in the 1.7 Mb region between positions 40,197,592 – 
41,904,861 on CFA 17 (CanFam2.0) were used for the fine-mapping. Of these, 48 
SNPs were typed on a MassARRAY Analyzer (Sequenom, San Diego, CA) and 30 
SNPs and one indel polymorphism were genotyped by re-sequencing of targeted 
PCR products using capillary sequencing technology. Finally, genotypes of 32 SNPs 
in this region were derived from the Affymetrix SNP microarray data explained in 
the previous chapter. Haplotypes were determined using linkage analysis package 
Merlin (http://www.sph.unich.edu/csg/abecasis/Merlin) [122]. 
3.8 Analysis of the canine FOXI3 gene and mutation 
identification (II) 
The bacterial artificial chromosome (BAC) clone S027P16A10 containing the canine 
FOXI3 gene was isolated using PCR screening of hierarchical DNA pools of a 
canine BAC library (6). The FOXI3 gene was subcloned in overlapping plasmids. A 
primer walking strategy with ABI 3730 capillary sequencer (Applied Biosystems, 
Foster City, CA) was performed to obtain the sequence of FOXI3. The sequence was 
submitted under accession AM998820 to the EMBL nucleotide database. 
3.9 Mice (III) 
Embryos  aged  from  E9  to  E19  from  NMRI  mice  were  collected  to  be  used  in  the  
experiments where wild-type embryos were needed. The appearance of the vaginal 
plug was determined to be day 0.5 of embryogenesis (E0.5) and the age of the 
embryos was more precisely approximated by morphological criteria. The following 
transgenic and mutant mouse lines were used and genotyped as described in the 
referred articles: Sostdc1 (ectodin) null [86], K14-Eda [73], and Eda null (Tabby) 
[72]. The ?-cat?ex3K14/+ mice were generated by cross breeding K14-cre and ?-
cateninlox(ex3) mice [123,124]. Littermates were used as controls for all other 
transgenic mice except for Eda null which were maintained by breeding Eda-/- 
females with Eda-/Y males. Experiments on mice were approved by the Animal 
Ethics Committee at the State Provincial Office of Southern Finland 
(ESAVI/1181/04.10.03/201, KEK10-056 and VKL001-08). 
3.10 In situ hybridization (II, III) 
Non-radioactive in situ hybridization (ISH) on paraffin sections (5-7 µm) was 
performed with the Ventana Discovery ISH robot (Ventana Medical Systems, Oro 
Valley,  AZ).   Whole-mount  ISH was  carried  out  using  the  InsituProVS instrument  
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(Intavis Bioanalytical Instruments AG, Köln, Germany). Digoxigenin (DIG)-labeled 
cRNA probes were used for both non-radioactive applications and were following: 
Foxi3 [91], Dkk4, Fgf3, Sostdc1, Patched1, and Lef1 [82,125]. Sense probes were 
used as controls. The probes were detected with BM Purple AP Substrate 
Precipitating Solution (Roche Applied Science, Basel, Switzerland). The samples 
were visualized and photographed with Leica stereomicroscope equipped with a 
DC300F camera and IM1000 software (Leica Microsystems, Wetzlar, Germany). 
For vibratome sectioning, the samples were embedded into 5% low-melting agarose 
and  cut  to  sections  (20-25  ?m)  with  Leica  VT  1000S  Vibratome  (Leica  
Microsystems, Wetzlar, Germany). Radioactive ISH on paraffin sections was 
performed using a standard protocol with 35S-UTP labeled probes (PerkinElmer, 
Waltham, MA). 
3.11 Tissue culture (III)  
Wild-type NMRI mouse embryos were dissected in sterile Dulbecco’s PBS pH 7.4 
under a stereomicroscope. For bead experiments Affi-Gel agarose beads (BioRad, 
Hercules, CA) were incubated in one of the following protein solutions: activin A, 
BMP4 and Shh (100ng/ ?l; R&D Systems, Minneapolis, MN). Heparin acrylic beads 
(Sigma,  St  Louis,  MO)  were  used  for  the  incubation  of  FGF4  (100ng/?l;  R&D  
Systems, Minneapolis, MN). Control agarose and heparin beads were soaked in 
bovine serum albumin (BSA, 1µg/µl, Sigma, St Louis, MO). Beads were placed on 
top of the tissue explants using fine forceps. Tissue explants were cultured for 24 
hours at 37?C in a Trowell-type organ culture system on Nuclepore filters (0.1 ?m) 
(Whatman, Kent, UK) in Dulbecco’s minimum essential medium (DMEM) 
supplemented with 10% fetal calf serum, glutamine and penicilline-streptomycin.  
3.12 Hanging-drop experiments and quantitative RT-PCR 
(III) 
Foxi3 mRNA levels in embryonic skin explants were analyzed substantially as 
described earlier [76]. In brief, the back skin of Eda-/- or wild type E14.5 mouse 
embryos was dissected and the explants were split  along the midline: one half  was 
used as a control while the other one was incubated with 0.25 ?g/ml of recombinant 
Eda protein (Fc-Eda-A1; [126] ) or 0.5 ?g/ml of activin A [127] in a hanging drop of 
Dulbecco's minimum essential medium (DMEM) supplemented with 10% fetal calf 
serum, glutamine and penicillin–streptomycin. After 2 and 4 hours of culture, total 
RNA was isolated using RNeasy mini kit (Qiagen, Venlo, Netherlands), and reverse 
transcribed using 500 ng of random hexamers (Promega, Fitchburg, WI) and 
Superscript II (Invitrogen, Carlsbad, CA) according to the manufacturers’ 
instructions. The hanging drop experiments were done twice each with minimum 
four replicates. Quantitative RT-PCR was performed using Lightcycler DNA Master 
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SYBR Green I with the Lightcycler 480 (Roche Applied Science, Penzberg, 
Germany). Gene expression was quantified by comparing the sample data against a 
dilution series of PCR products of RAN binding protein 1 (Ranbp1), follistatin, 
Edar, or Foxi3. Data were analyzed with the software provided by the manufacturer 
and normalized against Ranbp1. Statistical significance was tested by nonparametric 
Wilcoxon signed-rank test for paired samples, and p-value 0.05 was used as the 
significance threshold. 
3.13 Clinical and histological examination of Brazilian 
Terriers with skeletal abnormalities (IV) 
Seven affected Brazilian Terrier puppies, and a dam and three healthy littermates 
from five different litters were radiographically examined at the Animal Hospital of 
University of Helsinki to study the structural abnormalities. Laterolateral radiograph 
of the whole body and laterolateral  as well  as ventrodorsal  radiographs of the skull  
were obtained. Affected and healthy puppies were photographed and video recorded. 
Ophthalmoscopic examination was performed for three affected puppies by a board-
certified veterinary ophthalmologist. General post mortem examination was 
performed for three affected puppies from the same litter at the Animal Hospital of 
University of Helsinki. Autopsies were taken from different tissues including lung, 
kidney, spleen, heart, pituitary gland, brain, eye, long and short bones of the limbs 
and spine. In addition, histological analyses from tissue samples (limb bones, spine, 
skull and mandible with teeth) were later performed for four additional affected 
puppies. Histological samples from the Brazilian Terrier puppy that had died due to 
intestinal infection at 5 weeks of age and was without the skeletal disease was used 
as a control dog. Tissue samples were fixed in 10% formalin for 48 hours, bone 
samples were decalcified in Morse’s solution or in 10% EDTA, dehydrated and 
embedded in paraffin. Paraffin blocks were cut into 5?m sections and stained with 
hematoxylin and eosin. 
3.14 Biochemical studies of GAGs (IV) 
Urinary samples were collected and GAG levels (expressed as GAG/creatinine 
ratios) were measured from three cases and controls using a protocol for colorimetric 
quantification of GAGs based on de Jong et al. [128]. Serum samples were collected 
from three cases and six controls (three heterozygous carriers and three healthy non-
carriers). The samples were stored and shipped at -20°C to the laboratory of Oulu 
University Hospital for determination of the activity of ?-glucuronidase and ?-
mannosidase according to routine protocols.  
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3.15 Prediction of the pathogeneity of a genetic variant 
(IV) 
Web-based software PolyPhen-2 (Polymorphism Phenotyping v2) 
(genetics.bwh.harvard.edu/pph2) [129] was applied to evaluate the pathogenic effect 
of the mutation. The score range for PolyPhen-2 is from 0 to 1 with the threshold 
“probably damaging” at 0.85.  
3.16 Target enrichment and next generation sequencing 
(IV) 
A targeted sequence capture and next generation sequencing was performed to 
identify the disease-causing mutation. The NimbleGen’s in-solution capture 
technology was used to enrich a 13.2-Mb target region (CFA6: 3,250,000-
16,400,000) for sequencing using probes that were designed by Roche NibleGen 
(Roche NimbleGen, Madison, WI). The target enrichment and sequencing was 
performed for two Brazilian Terrier cases and controls with opposite haplotypes and, 
in  addition,  for  8  Border  Terriers,  12  Nova  Scotia  Duck  Tolling  Retrievers,  8  
Schipperkes, and 4 West Highland White Terriers, that were used as additional 
controls. Sample preparation, target enrichment experiments, sequencing and variant 
calling  pipeline  analysis  [130]  was  performed  by  the  core  facility,  Institute  for  
Molecular Medicine Finland (FIMM, Technology Centre, University of Helsinki, 
Helsinki, Finland) and has been described in detail in Study IV. Further data analysis 
was performed using open source R environment (http://www.r-project.org) and 
ANNOVAR software [131]. Canine genome build CanFam2 was used as reference 
sequence. 
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4 Results and discussion 
4.1 Genetic screening of T in multiple breeds with short-
tail phenotype (I and unpublished data) 
Natural short tail is a feature that exists in many breeds. Most of the breeds include 
both long and short-tailed dogs but there are also breeds in which the phenotype is 
fixed. Length of a short tail is variable (I/Fig. 1). The number of caudal vertebrae 
varies in short-tailed dogs and determines the length of the tail. A mutation causing 
dominantly inherited short tail in Pembroke Welsh Corgis and Corgi-Boxer crosses 
had been identified prior to this study to T gene belonging to a T-box transcription 
factor gene family [34]. The identified missense mutation (c.189C>G) (Fig. 6A,B) 
resulting in p.I63M substitution was suggested to be embryonic lethal in the 
homozygous condition. But as many different types of breeds include short-tailed 
dogs and some with apparently different mode of inheritance, we wanted to explore 
which breeds had the same mutation in the T gene and which breeds showed the 
short-tail phenotype without the known T mutation and could be thus used to 
identify novel mutations causing short tail, the mild form of caudal dysplasia.   
 
Figure 6. Heterozygosity for c.189C>G mutation in T gene causes short tail phenotype in 
dogs. The mutation is located in the end of exon 1 that codes for part of the DNA-
binding domain of T protein (A and B). 
4.1.1 Mutation in T is responsible for the short-tail phenotype in 17 
breeds but excluded in 6 breeds 
Short-tailed dogs were sought from breeds in which the short tail is a common and 
desired phenotype but also from breeds which had only occasional short-tailed dogs 
and the phenotype was not selected for. The T gene c.189C>G (p.I63M) mutation 
was genotyped from 360 dogs representing 23 breeds (I/Table 1). The study cohort 
included 156 short-tailed and 204 long-tailed dogs. The mutation was identified in 
short-tailed dogs within 17 breeds (I/Table 1). In the rest of the breeds (n=6) only the 
wild type allele was found (I/Table 1). In order to find out novel causative variations 
in T gene, all the coding exons, exon/intron boundaries, and untranslated regions 
(UTR) were sequenced but no variants associated with the phenotype were found. 
These results demonstrate that the T gene mutation is present in many short-tailed 
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dogs, but it does not explain all short tail phenotypes which indicates that other 
genetic alterations are likely involved in this phenotype in some breeds.  
In this study, 17 breeds were identified, in addition to Pembroke Welsh Corgi, 
with the T c.189C>G mutation, suggesting an ancestral origin of this mutation. 
Indeed, these 17 breeds mainly belong to two groups: sheepdog and hunting breeds. 
Writings in the beginning of 19th century indicate that naturally short-tailed 
sheepdogs were common in Britain in those days. It is likely that the T mutation has 
its origin in these sheepdogs or their ancestors. Modern dog breeds have been 
created subsequently and therefore the mutation has presumably spread to several 
breeds originating from these sheepdogs. And indeed, these short-tailed sheepdogs 
have been mentioned in the history of several breeds. A more recent addition of the 
mutation into some breeds is likely as well since a short tail has been a desired 
characteristic in many breeds and as an autosomal dominant feature it is easily 
transmitted.   
The studied short-tailed dogs with wild type T allele, c.189C, belong to six 
breeds, which are Boston Terrier, English Bulldog, King Charles Spaniel, Miniature 
Schnauzer, Parson Russell Terrier, and Rottweiler. The tail phenotype differs 
between the breeds suggesting heterogeneous genetic backgrounds. Boston Terriers 
and  English  Bulldogs  all  either  lack  or  have  very  short  and  kinky  tails,  commonly  
referred as screw tail due to its characteristic appearance.  In these breeds, the short 
tail is a breed characteristic and a fixed trait. The mode of inheritance has been 
suggested to be autosomal recessive [132]. Especially English Bulldogs could be 
studied further and compared genetically to other breeds of the same origin, namely 
the American and Continental Bulldogs (not recognised by FCI) that have normal 
long tails. On the other hand, short tail with multiple prominent kinks seems to be a 
very common, but not fixed, phenotype in King Charles Spaniel. Further analyses 
should be made to determine the mode of inheritance and the genetic alteration 
resulting in this short-tailed phenotype. Dogs with natural short tail were also found 
among Miniature Schnauzers, Parson Russell Terriers and Rottweilers. All the short-
tailed dogs from these breeds in the study had normal long-tailed parents. This 
suggests that the traits are due to either a recessive single locus mutation, 
spontaneous developmental abnormality (congenital but not hereditary), or a 
sporadic de novo mutation. In mouse, mutations in several genes such as Pax1, Wnt-
3a, DII3, Noto, and Ptf1a have been associated with short and kinked tails and, thus, 
also remain as potential candidates in dogs [46]. 
4.1.2 Reduced litter size indicates lethality of homozygous embryos 
Mice homozygous for the different T mutations die during embryogenesis and 
possess  severe  abnormalities  in  the  posterior  body  [42,49].   Lethality  of  the  
homozygous mutation has been suggested in dogs as well, since no dogs 
homozygous for the T mutation were found within the study identifying the T 
c.189C>G mutation. Further evidence was gained when Pembroke Welsh Corgi 
puppies with severe anatomical defects were reported to be homozygous for the 
mutation [35]. Therefore, it has been suggested that the homozygous mutation results 
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in either embryonic or, in rare cases, early postnatal lethality due to serious 
developmental defects. Our results showed that all short-tailed dogs with the T 
c.189C>G allele were heterozygous for the mutation and none of the long-tailed 
dogs carried the mutation. This result is in concordance with autosomal dominant 
mode of inheritance with complete penetrance and supports the previous assumption 
of the lethality of the homozygous mutation. In order to provide further proof for the 
embryonic lethality of the homozygotes, we compared the average litter size of two 
breeding combinations (long tailed _ long tailed and short tailed _ short tailed) in 
Swedish Vallhunds. We calculated the litter sizes of 56 litters born between years 
2000 and 2007 using the Breeding Database from the Finnish Kennel Club (2008) 
(jalostus.kennelliitto.fi). The average litter sizes were 5.5 puppies for long_long and 
3.9 puppies for short_short breeding combinations (I/Fig. 2). Breeding short-tailed 
dogs together produced, on average, 29% (P = 0.0008) smaller litters compared to 
litters of long-tailed dogs of the same breed.  This is close to the expected value 
(25%) when hypothesizing the in utero lethality and therefore, provides further 
support for the hypothesis that the T mutation is homozygous embryonic-lethal.  
Although the short-tail phenotype as such has no counterpart in human, it is a 
posterior truncation and could be seen to represent a mild form of caudal dysplasia. 
The identification of the novel mutations might provide information regarding the 
genes that regulate the development of the caudal most structures and/or the 
vertebrae.  
4.1.3 A puppy homozygous for T mutation with severe caudal 
dysplasia (unpublished data) 
A malformed Swedish Vallhund puppy was delivered to the laboratory for 
examination. The puppy had been born alive but euthanized shortly after birth due to 
multiple severe malformations. Both sire and dam of the puppy were congenitally 
short-tailed dogs. The puppy was tailless and had hypoplastic lower limbs, 
abdominal hernia and anal atresia (absence of the anus). The radiography and 
computed tomography (CT) scan with volume rendering technique showed severe 
vertebral malformations including missing sacral and caudal vertebrae (Fig. 7). 
Genotyping revealed that the puppy was homozygous for the T c.189C>G mutation. 
The phenotype is comparable with the previously reported Welsh Corgi Pembroke 
puppies which also were homozygous for the T mutation [35]. This provides further 
support that the homozygotes might occassionally survive until birth. These 
homozygotes have features typical for caudal dysplasia or caudal regression 
syndrome, which is a congenital malformation in human characterized by varying 
degrees of developmental defects of posterior body in early embryogenesis. In 
addition, the canine phenotype is in concordance with the mouse hypomorphic 
phenotype caused by in vivo knockdown of T which was demonstrated to result in 
axial skeletal defects and urorectal malformations resembling human caudal 
regression syndrome [51]. Together these studies indicate that defected function of T 
can result in caudal dysplasia syndrome. 
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Figure 7.  A whole body CT scan (ventral, slightly oblique view) of Swedish Vallhund puppy 
with severe spinal dysmorphism and caudal dysplasia.  
4.1.4 T c.189C>G mutation is ancestral and causative for short tail 
phenotype in several, but not all, breeds 
Short tail in dogs is a phenotype that has been favoured by man and therefore has 
been deliberately selected for. Short tail is a fixed breed characteristic in some 
breeds but in many breeds tail phenotype has remained variable. Screening of 
previously identified T c.189C>G mutation in 23 breeds revealed that the short tail is 
caused by the mutation in 17 different breeds. This demonstrates that the mutation is 
widely spread and suggests that the mutation occurred in a common ancestor quite 
long time ago. On the other hand causative variants in T were not found in short-
tailed dogs belonging to six breeds. It will be interesting to see what the genes 
responsible for these traits are. Identification of genetic variant resulting in the short 
tail that is a fixed trait in several breeds could be successfully achieved using sweep 
mapping as these breeds likely share the same causative genetic variant. 
Alternatively, NGS approaches, namely exome or whole genome resequencing 
might be successful. Morover, it will be important to characterize the phenotypes of 
these short-tailed dogs thoroughly as the abnormalities in tail morphology may not 
be the only changes involved in the phenotype. Identification of the causative genes 
would then provide information about the function of these genes.  
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4.2 Identification of the FOXI3 mutation as causative for 
the canine ectodermal dysplasia (II) 
4.2.1 Mapping the CED to CFA17 in Chinese Crested dogs and fine-
mapping with Mexican and Peruvian Hairless dogs 
The characteristic hairless phenotype of three breeds, Chinese Crested, Mexican 
Hairless and Peruvian Hairless dogs, includes missing or abnormally shaped teeth 
and sparse or lacking hair (Fig. 8 and II/Fig. 1A,B). This autosomal dominant trait is 
classified as canine ectodermal dysplasia. CED was earlier mapped to large segment 
of CFA17 by linkage analysis using experimental matings [59]. With more recent 
techniques using substantially denser marker assays it was expected to be possible to 
map the disease more precisely in Chinese Crested dogs. We therefore decided to 
perfom GWAS and collected an initial cohort of 20 hairless and 19 coated Chinese 
Crested dogs. The samples were genotyped using Affymetrix 2.0 canine array with 
~50k SNPs.  A case-control association analysis detected strong association on 
CFA17 at position 41,039,521 (praw = 3.5 x 10-6, pgenome = 0.044) (II/Fig. S2A). No 
single SNP, however, segregated completely with the CED phenotype.  
 
Combinations of genetic variants locating at adjacent regions on the same 
chromosome and inherited together are called haplotypes. Association methods 
based on haplotypes may sometimes provide additional power for gene mapping. 
Therefore, haplotype association approach was conducted. Haplotype frequencies 
were determined using sliding windows of two to eight SNPs across the genome and 
the LOD scores were calculated. Consequently, 8-SNP haplotype sized 160 kb was 
revealed on CFA17 at a position ranging from 41.04 Mb to 41.20 Mb and having 
perfect concordance (II/Fig. S2B). 
As mentioned above, the CED phenotype segregates in three different breeds, 
which was taken advantage of in this study. We fine-mapped the locus in a cohort of 
195 dogs (140 cases and 55 controls) including Chinese Crested dogs (93 cases and 
49 controls), Mexcican Hairless dogs (8 cases) and Peruvian Hairless dogs (39 cases 
and 6 controls).  The haplotypes were determined by exploiting the familial 
relationships of the dogs in the cohort. All hairless dogs contained identical marker 
alleles in 102-kb region (II/Fig. S2C). This 102-kb haplotype located between 
41,045,331 and 41,147,100 bp on CFA17. Due to different recombination histories, 
the original extensive 1.7 Mb region of association, mapped in the Chinese Crested 
dog, was efficiently narrowed down with the other two breeds to only 102-kb region. 
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Figure 8. A hairless (CED affected) (left) and coated (right) Peruvian Hairless dog (A). A 
hairless Peruvian Hairless dog (B) and a head figure of another hairless dog 
demonstrating the sparse hair on top of the head (C). Malformed and missing 
incisors and canine teeth of a hairless dog (D). A normal dentition of a coated dog 
(E). All premolars are missing from the hairless dog (F). A normal dentition of a 
coated dog of same breed (G). 
The region contained only two predicted genes LOC483074 and LOC483075. 
LOC483074 represents a processed pseudogene of the X-chromosomal NONO gene. 
LOC483075 showed homology to the forkhead box (FOX) transcription factor gene 
family. Several members of the FOX family of transcription factors have been 
shown to function in different developmental processes [90] and therefore, it was 
considered to be a good candidate gene. 
There was one article published about mammalian Foxi3 reporting the expression 
of the mouse Foxi3 during early murine embryogenesis [91]. The expression 
analysis included only the stages before the organogenesis of the ectodermal 
appendages and therefore, the expression in the developing murine tooth and hair 
follicles, which are the organs mainly defected in the dogs with CED, was assessed 
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here. Whole-mount ISH of the E13.5 and E14.5 mouse embryos revealed specific 
expression of Foxi3 transcripts  in  the  epithelium  of  the  hair  and  whisker  placodes  
and developing teeth (both molars and incisors) (II/Fig. S3). This suggested a 
functional role for Foxi3 in the development of these organs and triggered to the 
search for a mutation related to this gene.  
The  canine  dog  assembly  CanFam2.0  did  not  cover  the  entire  exon  1  of  
LOC483075 because of a sequence gap within that region. Therefore a BAC clone 
corresponding to this region was isolated and the complete genomic sequence of 
FOXI3 and its upstream sequence (accession AM998820) were determined. This 
previously uncharacterized canine gene showed highest similarity to the mouse 
Foxi3 gene. Like most other FOX genes, the coding sequence of the canine FOXI3 
gene is contained within two relatively large exons (II/Fig. S4). The first exon and 
the putative promoter region are GC-rich (>85%) (II/Fig. S4). Multiple alignments 
across mammalian FOXI3 protein sequences were performed (II/Fig. S5). The 
canine FOXI3 protein is predicted to contain 436 amino acids with 74% identity to 
the murine Foxi3 protein. 
Sequence analysis of the FOXI3 gene in hairless and coated Chinese Crested 
dogs revealed a 7-bp duplication (c.57_63dup7) within exon 1 leading to a 
frameshift and a premature stop codon (p.A23fsX219) (II/Fig. 1B and Fig. S4). In 
order to validate the mutation, an additional cohort of dogs was genotyped, including 
all three studied breeds (140 hairless and 55 coated dogs) and 19 other breeds (32 
coated dogs). The duplication was found to segregate perfectly with the dominant 
CED phenotype. All the CED dogs were heterozygotes and no homozygotes for the 
mutation were found. 
The identified duplication leads to a frameshift and a premature stop codon quite 
downstream. Consequently the encoded protein would be truncated and include 218 
altered  amino  acids.  More  than  95%  of  the  normal  protein  would  be  missing  and  
therefore the protein would likely be disfunctional. Thus, the CED phenotype in 
hairless dogs is possibly caused by haploinsuffiency of FOXI3. The lack of dogs 
which are homozygotes for the mutation is consistent with the previous hypothesis 
of the lethality of the homozygous genotype and thus, the results also indicate that 
half the amount of the protein is not enough to fully accomplish the functions of 
FOXI3.  
4.2.2 Identification of FOXI3 mutation indicates an essential function 
for FOXI3 in the development of ectodermal organs 
Identification of the FOXI3 mutation as a causative gene for the CED and its specific 
expression in the developing teeth and hair follicles suggested a novel and 
significant  function  for  FOXI3  in  the  development  of  these  ectodermal  organs.  It  
also provides a novel candidate gene for human ectodermal dysplasias. 
FOXI3 mutation has been found only in three breeds of dogs with similar hair 
and tooth phenotype and other ectodermal anomalies that are not described by the 
breed standards. The three breeds also are presumed to be closely related, based on 
their history, and actually could be variations of the same common ancestor. This 
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further suggests that the mutation in FOXI3 is again an ancestral mutation with a 
common origin.  
4.3 Regulation of Foxi3 expression during ectodermal 
development in mouse (III and unpublished data) 
4.3.1 Foxi3 expression in mouse  
Prior to identification of the mutation in FOXI3 as causative for CED, only one 
article was published about the mammalian Foxi3 describing the expression during 
early mouse embryogenesis (E6.5 to E10.5) and suggesting a role for Foxi3 in 
pharyngeal organ development and specification of cranial placodes [91]. Therefore, 
the function of Foxi3 was explored here, commencing with a detailed expression 
pattern of Foxi3 during the developmental stages of tissues that are relevant for the 
development of the ectodermal organs focusing on developing teeth, hair follicles, 
and mammary glands. 
4.3.1.1 Foxi3 expression during tooth morphogenesis 
Mouse dentition differs from carnivores as it lacks the canines and premolars, and 
instead consists of one continuously erupting incisor and three molars separated by a 
toothless diastema region in each jaw quadrant. At E11.5, a thickening of the oral 
epithelium  (dental  lamina)  marks  the  future  site  of  the  dental  arch.  ISH  of  E11.5  
mouse embryos showed that Foxi3 was strongly expressed throughout the dental 
lamina of the maxilla and mandible (III/Fig. 1A,B). At E12.5 Foxi3 expression was 
downregulated in the toothless diastema region but was persistent in the emerging 
placodes of incisors and molars (III/Fig. 1C and Fig. 5E). As tooth formation 
progressed, Foxi3 expression maintained in the entire dental epithelium until E13.5 
and was not restricted to the enamel knot signaling center only. Subsequently at the 
cap stage of molar development, Foxi3 expression became asymmetric, being more 
intensely expressed in the lingual side of the tooth bud (III/Fig. 1E).  At later stages 
of molar morphogenesis (E17-E18), Foxi3 was expressed at high levels in the inner 
enamel epithelium (III/Fig. 1F,G), which marks the precursors of enamel producing 
ameloblasts. In addition, a weaker expression was detected in the outer enamel 
epithelium  and  in  stellate  reticulum  (III/Fig.  1F,G).  By  postnatal  day  2,  Foxi3 
expression was downregulated from the differentiated ameloblasts of the molars but 
remained in the stellate reticulum cells, in the stratum intermedium, and in the 
cervical loops (III/Fig. 1H). In conclusion, Foxi3 expression was confined only to 
the epithelial compartments starting from the first developmental stages and 
continuing until the late stages of dental morphogenesis. The expression was 
downregulated, however, from the cells of the inner enamel epithelium when they 
differentiated into ameloblasts. This suggests that Foxi3 has an impact in the 
initiation and morphogenesis of teeth but not in enamel formation. 
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4.3.1.2 Foxi3 expression during hair follicle morphogenesis 
In Study II, Foxi3 was demonstrated to be expressed in the follicles of developing 
vibrissae and hair follicles by whole-mount ISH [133]. More thorough expression 
analysis with non-radioactive and radioactive ISH on paraffin sections showed that 
Foxi3 expression was present in the hair placodes of all three hair follicle types 
(III/Fig. 2) which form in separate phases at E14.5, E16.5, and around birth [134]. In 
mouse, hair follicle development is initiated at E14-14.5 with the formation of the 
first, primary, hair placodes that give rise to guard hairs. At this stage, E14.5, Foxi3 
expression was clearly seen in the placodal epithelium of these primary hair follicles 
(III/Fig. 2A,B). At E16, the expression appeared to the secondary hair placodes that 
give rise to awl/auchene hairs, but also remained in the growing primary hair 
follicles (III/Fig. 2C). At E19, Foxi3 expression was detected in all hair follicle types 
including further maturing primary and secondary, and nascent tertiary hair placodes 
that  give  rise  to  zig  zag  hairs  (III/Fig.  2D).  It  is  noteworthy  that  throughout  the  
organogenesis of both teeth and hair follicles, the expression was confined only to 
the epithelial cells. 
4.3.1.3 Foxi3 expression in other ectodermal organs 
Foxi3 expression was also analyzed during other ectodermal organ development, 
namely during morphogenesis of mammary, salivary and sweat glands. In mice, 
mammary gland development is initiated at around E11 starting from the most 
posterior pair of glands. By E12.5 all five pairs of mammary buds have formed 
[135]. Foxi3 expression  was  detected  in  the  epithelium  of  all  mammary  buds  by  
radioactive ISH at E12.5 (III/Fig. 3A and 4H). However, the expression was no 
longer detected at later stages when mammary gland morphogenesis had progressed 
(III/Fig. 3B and 4K). Foxi3 expression was also detected in a subset of epithelial 
buds at E14.5 by radioactive ISH, apparently representing the sublingual gland, as 
well as in minor salivary gland buds (III/Fig. 3C,D). Low levels of Foxi3 transcripts 
were detected in developing eccrine sweat glands at E18.5 similar to Edar 
expression (III/Fig. 3E,F).  
Whole-mount ISH on whole mouse embryos and tissues revealed Foxi3 
expression in several other tissues as well. Foxi3 expression had been previously 
demonstrated in the region between maxilla and mandible, in the branchial pouches 
and the dorsal part of the optic cup at E9.5 to E10.5 [91]. In addition to these sites, 
an  intense  expression  around  the  anal  opening  was  observed  at  E9  (III/Fig.  3G).  
Moreover, the expression in the optic cup was also maintained at later stages of eye 
development (until E16.5) (III/Fig. 3H-J). The expression was strongest in the dorsal 
and ventral regions of the optic cup at E11.5, but later became restricted to the most 
anterior parts. This spatiotemporal expression pattern of Foxi3 in the eye suggests 
that it also has a function in the development of the neural retina. In addition, Foxi3 
was detected in the epithelium of the maxillary process and in the nasolacrimal 
groove at E11.5 (III/Fig. 3H,K) and at E14.5 at the sites of nail primordia and around 
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future tactile pads (III/Fig. 3L). The tactile pads begin to develop at this stage and 
will eventually give rise to footpads. 
4.3.2 Foxi3 has a function in multiple organ systems (unpublished 
data) 
In addition to teeth and hair follicles, these expression analyses indicate a possible 
function for Foxi3 in a few other ectodermal organs and together with the previously 
published expression analysis [91] in other organ systems as well. There is no 
scientific evidence that the canine FOXI3 mutation would alter other ectodermal 
organs than tooth and hair follicle. A recent article described histological 
characteristics of hair follicles and glandular tissues of Chinese Crested dogs [57] 
demonstrating that the hairless dogs with FOXI3 mutation had abnormal hair 
follicles whereas the apocrine glands in the skin and respiratory mucous glands were 
normal. However, the canine phenotype is caused by a heterozygous FOXI3 mutant 
allele likely representing a haploinsufficiency and therefore it is expected that the 
canine phenotype does not correlate completely with the functions of FOXI3 in 
different organ systems. The homozygous FOXI3 mutant dogs die during 
embryogenesis [136] and so do the Foxi3-/- transgenic mice (personal 
communication with Andrew K. Groves), which implies severe defects in vital organ 
systems due to complete loss of Foxi3 function. Interestingly, Letard [55] has 
reported  that  as  a  result  of  experimental  breeding  of  two  hairless  dogs  some  non-
viable puppies with severe orobuccal malformations were born. This raises a 
question as to whether these puppies were homozygous for FOXI3 mutation or 
maybe just very severily affected heterozygotes. Most likely they, indeed, were 
homozygotes as the Foxi3-/- embryos have very severe inner, middle, and external 
ear as well as lower jaw phenotype (personal communication with Andrew K. 
Groves). Puppies with equally severe anomalies have not been reported by breeders 
of hairless dog breeds, altough mild malformations of the outer auditory canal 
(closed ear canal) and ear lobe are not rare findings (The Society of Finnish Chinese 
Crested Dog, http://www.kiinanharjakoirat.fi, and personal communication with 
breeders of Mexican and Peruvian Hairless Dogs). We have also performed a clinical 
examination,  CT  scan,  and  autopsy  for  one  Peruvian  Hairless  dog  that  was  
euthanized at the age of 4 weeks due to auditory defects (unpublished data). The 
examinations showed that the the dog lacked an outer auditory ear canal and had 
small tympanic cavity on the right side but had normal hearing and ear anatomy on 
the left side (Fig. 9). This suggests that FOXI3 might  also  have  a  role  in  the  
morphogenesis of external structures of ear. Interestingly, some dogs with missing 
anal opening also have been reported by the breeders in all three breeds. As mouse 
Foxi3 was expressed around the anal opening as early as E9, it can be suggested that 
Foxi3 regulates the formation of this ectodermal structure as well. 
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Figure 9. Auditory structures of a Peruvian Hairless puppy. CT scan demonstrates that the 
outer auditory canal is missing and tympanic cavity is smaller on the right side 
compared to the normal structures on the left side of the head. Scale bar is 1 cm. 
4.3.3 Foxi3 lies downstream of Eda in skin appendage placodes and 
buds 
Eda/Edar signaling pathway has a significant role in the development of tooth and 
hair follicle and the mutations in these genes are the most common cause of human 
HED [18,71]. In dogs, the FOXI3 mutation results in ED indicating Foxi3 to be 
essential in ectodermal organogenesis. Additionally, similar to Foxi3, expression of 
Edar and activity of transcription factor NF-?B, the essential downstream mediator 
of Eda/Edar, is high in all skin appendage placodes [71,137]. These similarities 
promoted the exploration of the interplay and hierarchy in the Foxi3 and Eda/Edar 
signaling pathway. Eda-deficient and overexpressing mouse lines were employed to 
explore this. Eda-deficient mice lack primary hair placodes and have hypodontia and 
abnormally shaped teeth [72], whereas Eda-overexpressing mice (K14-Eda) are 
characterized by enlarged hair and/or ectopic hair, tooth and mammary placodes 
[73,74]. The expression of Foxi3 in tooth, mammary buds and hair follicles was 
assessed in Eda mutant embryos compared with wild type controls. Foxi3 expression 
was reduced in the tooth buds of Eda-deficient and increased in K14-Eda embryos at 
E13.5 compared with control littermates (III/Fig. 4A–C). Similar correlation was 
seen in the mammary buds at E12.5 (III/Fig. 4G–I).At E13.5 when Foxi3 expression 
was no longer detected in control and Eda null mammary buds, it was readily 
observed in the endogenous and ectopic mammary buds of K14-Eda mice (III/Fig. 
4J–L).No Foxi3 expression was detected in the dorsal skin of Eda-deficient embryos 
at E14.5 (III/Fig. 4D), which is not suprising as the primary hair placodes are 
missing in these mutants. Instead, the expression was slightly increased in the 
primary hair placodes of K14-Eda embryos compared with control littermates 
(III/Fig. 4E,F). These findings suggest that Foxi3 lies downstream of Eda signaling 
but whether Foxi3 is a direct target of Eda cannot be verified based on these 
experiments. 
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The ability of recombinant Eda protein to upregulate Foxi3 expression in E14.5 
Eda-/- skin explants was analyzed in order to determine whether Foxi3 could  be  a  
direct target gene of Eda [76,138]. Skin explants dissected from E14.5 mouse 
embryos were treated with Eda protein added to the culture media and the Foxi3 
expression was measured by RT-PCR at two different time-points and compared to 
the Foxi3 mRNA levels in untreated control explants. Only a 2h-exposure to Eda led 
to a 12-fold induction of Foxi3 mRNA level and >20-fold induction after 4h-
exposure (III/Fig. 4M). This identifies Foxi3 as one of the most rapidly upregulated 
Eda-induced genes [76,125,138]. The swift and pronounced induction of Foxi3 
expression by Eda strongly suggests that Foxi3 is a direct transcriptional target of the 
Eda pathway.  
Possible NF-?B binding sites were sought from the Foxi3 promoter region with 
the Consite program (http://asp.ii.uib.no:8090/cgi-bin/CONSITE/consite/) in order to 
gain further evidence for the direct regulation of Foxi3 by Eda signaling. Indeed, 
several putative NF-?B sites were found in the Foxi3 promoter  region  in  all  
mammalian species tested. One of these sites (GGTGCTTTCC in the mouse), 
located near the 5’ end of the sole Foxi3 intron, was conserved in multiple species 
(data not shown).  However,  all  the found elements are solely putative binding sites 
and further studies will be required to determine their functional relevance. 
4.3.4 Foxi3 expression is unaffected in mice with increased Wnt 
signaling activity 
Together with the Eda/Edar pathway, canonical Wnt signaling regulates hair follicle 
development and also has an essential function in tooth and mammary bud formation 
[139]. The expression pattern of Foxi3 in the developing ectodermal appendages has 
been reported to overlap with the sites of high Wnt/?-catenin signaling activity i.e. 
hair, tooth and mammary placodes and buds [84,140,141]. Therefore, the possibility 
that Wnt signaling could regulate Foxi3 was investigated by Foxi3 expression 
analysis in the embryos of two transgenic mouse lines, ?-cat?ex3K14/+ and Sostdc1-/-. 
In ?-cat?ex3K14/+ embryos forced stabilization of ?-catenin in the embryonic ectoderm 
causes formation of supernumerary enamel knot signaling centers leading to 
continuous tooth generation, as well as precocious and ectopic hair follicle 
development [84,85]. Foxi3 expression was observed both in the ectopic signaling 
centers  in  the  oral  epithelium  and  in  the  ectopic  hair  placodes  at  E14.5,  but  no  
differences were seen in the expression levels between the ?-cat?ex3K14/+ and control 
embryos (III/Fig. 5A–D).  
Sostdc1 (also known as ectodin and Wise) is an antagonist of both Bmp and Wnt 
signaling pathways [142,143]. Sostdc1-deficient mice feature extra incisors, 
premolar like teeth, enlarged hair placodes, and ectopic whisker buds that are 
thought to be caused by elevated Wnt/?-catenin signaling activity [86-89]. Whole 
mount ISH did not reveal changes in the expression level of Foxi3 in the tooth and 
hair placodes of Sostdc1-/- embryos compared to the wild type embryos (III/Fig. 5E–
H).  These  results  together  suggest  that  Foxi3  is  not  a  target  of  the  canonical  Wnt  
pathway. 
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4.3.5 Activin A regulates Foxi3 expression in vitro 
Other molecular mechanisms that could regulate Foxi3 expression, in addition to 
Eda signaling, were exlopred. The targets of interest were the signaling pathways 
with an important function in ectodermal organ development: activin, Bmp, Fgf and 
Shh signaling [69,70]. Protein-absorbing beads on wild-type mouse embryonic skin 
cultures were used and Foxi3 expression was detected by whole mount ISH (III/Fig. 
6A–E). The beads soaked in activin A, Bmp4, Fgf4, Fgf10, or Shh were placed on 
top of the skin explants separated from mouse embryos at E13.5, just prior to the 
induction of primary hair follicles, and the explants were cultured for 24 hours. The 
whole  mount  ISH  of  the  cultured  explants  revealed  a  strong  induction  of  Foxi3 
expression in the epithelium around the activin A -releasing bead (III/Fig. 6D). Fgf4, 
Fgf10, or Shh had no effect on Foxi3 expression (III/Fig. 6A,B and data not shown). 
Bmp4-releasing beads have previously been shown to inhibit hair placode formation 
[76]. It has been, however, shown that Bmp4 is able to induce target gene expression 
in the tissue surrounding the bead [143]. As expected based on these previous 
results, there was no hair placode formation around Bmp4-soaked bead, but no 
ectopic induction of Foxi3 expression in the tissue either (III/Fig. 6C).  
In the bead experiments, the exposure time of the protein to the tissue is 
relatively long and the expression cannot be quantitatively measured by ISH. Thus, 
the observed results reveal a long-term overview of the effect of the tested protein. 
Therefore, a similar approach as with Eda was used to investigate whether the 
upregulation of Foxi3 is  due to a direct  effect  to activin A exposure.  Skin explants 
from E14.5 mouse embryos were exposed to activin A and the Foxi3 expression was 
measured by RT-PCR after two and four hours.  The Foxi3 mRNA levels were 
compared to corresponding levels of untreated skin explants. Follistatin was used as 
a positive control as it is a known transcriptional target of activin. The quantitative 
measurements were consistent with the bead expriments as the activin A exposure 
produced a statistically significant 1.6-fold and 2.2-fold increase in Foxi3 mRNA 
levels  after  two  and  four  hours,  respectively  (III/Fig.  6F).  Follistatin  showed  an  
increase of 4.6-fold (III/Fig. 6F). Activin A has been proposed to regulate Edar 
expression [82,144], and thus the upregulation of Foxi3 after activin A exposure 
might be caused as a secondary effect through Eda signaling. Therefore, Edar 
mRNA levels after activin A exposure were also assessed. Expression of Edar turned 
out to be unaffected (III/Fig. 6F). Subsequently, to further confirm that activin A can 
induce Foxi3 expression independent of the Eda pathway, the activin A bead 
experiments were repeated using Eda null  skin  explants.  As  a  result,  activin  A  
induced Foxi3 expression in 5 out of 15 explants whereas BSA bead had no effect (0 
out of 7 explants) (III/Fig. 6G,H).  
The results from short- and long-term protein induction experiments indicate that 
activin A is a putative upstream regulator of Foxi3, which suggests a functional link 
between activin A and Foxi3 and imply that activin A can regulate the expression of 
Foxi3 in hair placodes independent of Edar. 
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4.3.6 Future aspects of exploring the functions of Foxi3 
The  aim  of  this  study  was  to  explore  the  function  of  Foxi3  in  mammalian  
embryogenesis. Therefore a detailed expression pattern of murine Foxi3 during the 
development of the ectodermal organs was constructed as well as tissue culture 
experiments and expression analyses with mouse embryos. The results imply that 
Foxi3 functions in the development of several ectodermal appendages, namely hair 
follicle, tooth, mammary and salivary gland, nail, but also in some other tissue 
compartments such as eye. The findings of this study suggest that Foxi3 lies 
downstream of Eda signaling and could even be a direct transcriptional target of the 
Eda pathway. In addition to Eda, activin A was indicated to be a putative upstream 
regulator of Foxi3. 
The almost total lack of hair especially in Mexican and Peruvian Hairless dogs is 
more prominent than the phenotype of canine X-linked ectodermal dysplasia caused 
by EDA mutation [60]. This further suggests that FOXI3 is not solely a target of 
Eda/Edar signaling pathway but it is regulated by additional factors, such as Activin 
A, as shown in this study, but maybe other signaling pathways as well. Downstream 
targets of FOXI3 remain to be explored, but based on the CED phenotype caused by 
the haploinsuffiency of FOXI3, these targets should be essential for the ectodermal 
development, and based on the expression pattern in mouse, could regulate the 
development of the whole facial region as well. 
In  the  future,  the  role  and  regulation  of  during  the  development  of  ectodermal  
organs will be more thoroughly explored. A transgenic mouse model, that has 
already been developed, will provide a valuble tool to unravel the function of Foxi3 
and its regulators and targets. The knowledge about the function of Foxi3 in different 
organ systems using mouse model will be of great interest to developmental 
scientists. Moreover, a detailed characterization of dogs with CED could bring some 
new information. Great attention is paid to see whether any FOXI3 mutations will be 
found in human ectodermal dyplasia or other disease patients. 
4.4 Identification of a novel GUSB mutation defines the 
hereditary skeletal disease in Brazilian Terriers as 
mucopolysaccharidosis VII  
A litter of seven Brazilian Terriers aged 4 weeks was examined in the Animal 
Hospital of the University of Helsinki because three of the puppies showed severe 
ambulatory defects. Later, several other related Brazilian Terrier litters with similar 
puppies were born and altogether 15 affected dogs from 8 different litters were 
confirmed  to  have  similar  clinical  signs,  although,  the  severity  of  the  phenotype  
varied even among the affected littermates. The congenital and progressive features 
became evident within the first four weeks of life. The affected puppies showed 
normal behavioural activities and appetite but had severe ambulatory difficulties. All 
affected puppies presented similar phenotypic characteristics with brachycephaly, 
dwarfism, deformed legs with crooked radiocarpal joints and prominent joint 
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hyperlaxity of the limbs (IV/Fig. 1A,C). Due to poor prognosis the affected puppies 
were euthanized between 2 to 6 weeks of age except for two puppies that died 
spontaneously  at  the  age  of  1  and  3  weeks  for  unknown reasons.  Both  sexes  were  
equally affected. 
4.4.1 Clinical and histopathological examinations indicate 
spondyloepiphyseal dysplasia 
Radiographs of seven affected dogs and three age- and sex-matched controls were 
compared to explore the cause for the structural abnormalities (IV/Fig. 2A-D). In 
addition, radiographs were taken from the dam of the first litter. Epiphyseal 
dysplasia of long bones and vertebral endplates with delayed ossification of the 
epiphyseal cartilages was evident in all affected dogs (IV/Fig. 2A,C). In addition, the 
ossification centers of the cuboid bones of the carpus and tarsus were reduced in size 
when compared to normal littermates (IV/Fig. 2A). Marked carpal and tarsal joint 
effusion was seen in all affected dogs. The craniofacial abnormalities included short 
maxilla (retrognathia superior) and widened calvaria (IV/Fig. 2E). Skeletal 
radiopacity was generally slightly decreased in the affected dogs, but the cortices of 
the long bones appeared normal. Ophthalmoscopic examination was performed for 
the three affected puppies from the first litter but revealed no pathological changes in 
the eyes. The affected puppies showed growth retardation weighing 35% less than 
their healthy littermates at the age of three weeks (IV/Fig. 1E). 
Postmortem tissues were collected from eight euthanized puppies for 
histopathological analyses. Histological examination of the skeletal structures of the 
affected puppies showed that secondary ossification centers in the epiphyses were 
either small or completely lacking and occassionally containing regions of loose 
fibrous  tissue  (IV/Fig.  2G,I).  Similarly,  the  ossification  centers  of  the  carpal  and  
tarsal bones were either lacking or were small and included thin and irregular 
primary trabeculae.  The vertebral bodies occasionally had irregular cartilage 
columns in the growth plate and inclusions of loose fibrous tissue (IV/Fig.  2J).  No 
gross abnormalities in the other tissues were found. 
4.4.2 GWAS maps the disease to CFA6 
A large pedigree was established tracing all the affected dogs back to a common 
Brazilian ancestor (IV/Fig. 3). Both males (n=7) and females (n=5) were equally 
affected. The affected puppies were always born to healthy parents and many litters 
included several affected puppies. The proportion of the affected dogs in the litters 
was 31,6%, which is close to an average of 25% assumed for a recessive condition. 
Therefore, an autosomal recessive mode of inheritance was assumed to be the most 
feasible choice for the mode of inheritance.  
We performed GWAS to map the disease locus and genotyped altogether 18 
Brazilian Terriers including 7 cases and 11 controls using Illumina’s 22K canine 
SNP array. A case-control association test revealed significant association on CFA6 
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with the best SNP (BICF2G630808208) at 7,265,846 bp (praw = 1.86 x 10-5, pgenome= 
0.03313) (IV/Fig. 4A). All affected dogs shared a long homozygous haplotype 
adjacent to the centromeric end of the chromosome (CFA6:3,341,099-16,324,133 
bp) (IV/Fig. 4B). Moreover, the three obligate carriers (parents of the affected dogs) 
were heterozygous for the haplotype, as expected. The haplotype contained 137 
SNPs of which none showed a complete segregation between the cases, obligate 
carriers and controls. 
4.4.3 Next generation sequencing identifies a missense mutation in 
GUSB 
The associated locus contains a large number of genes (>210) and many of them 
were considered as potential candidate genes (IV/Fig. 4B). Two of them, 
Procollagen C-endopeptidase enhancer (PCOLCE) and SMAD ubiquitin regulatory 
factor 1 (Smurf1) were selected for further investigation but sequencing did not 
reveal any segregating coding variants in either of the genes. Subsequently, a 
targeted sequence capture was performed, in addition to next generation sequencing 
for  the  whole  13-Mb associated  region.  Two cases  and  two controls  with  opposite  
haplotypes were selected for capturing (IV/Fig. 4B). After the variant calling 
pipeline (VCP) analysis of the sequencing data, altogether approximately 13,000-
19,000 SNPs and approximately 5,000 indels were evident for each dog (IV/Table 
1). In addition, sequence data for 32 healthy dogs from four different breeds were 
available to be used as controls. Comparison of the variants between cases and 
controls revealed two novel homozygous exonic SNPs, one deletion, and one 
insertion, which were all unique for cases. The 9-bp deletion was located in the 
monoacylglycerol O-acyltransferase 3 (MOGAT3)  gene  (at  position  
BROADD2:6:11,681,043), which is an intestinal specific enzyme implicated in fat 
absorption [145]. The 3-bp insertion was located in the olfactory receptor, family 2, 
subfamily AE, member 1 (OR2AE1) gene (at position BROADD2:6:12,694,743). 
These as candidate genes were excluded due to their known specific function outside 
the skeletal  system. One of the exonic SNPs was synonymous. The other was non-
synonymous and located in the exon 5 (c.866C>T) of the ?-glucuronidase (GUSB) 
gene; this missense mutation results in a proline to leucine substitution at amino acid 
position 289 (p.P289L) (Fig. 10A and IV/Fig. 4D,E).  
The GUSB gene encodes a lysosomal ?-glucuronidase, an enzyme that degrades 
several GAGs. In human, deficient ?-glucuronidase activity causes a lysosomal 
storage disease, MPS VII. Mutations have, however, been described in many other 
species as well, including mouse, cat and dog [109,112,117,119,120]. In all of them, 
the enzyme deficiency leads to lysosomal storage of GAG’s in several tissues and 
several common clinical signs such as skeletal deformities, corneal clouding and 
hepatosplenomegaly. Dwarfism, joint hyperlaxity and epiphyseal dysplasia have also 
been reported in the dogs with previously identified MPS VII and these features are 
consistent with the affected Brazilian Terriers. Therefore, the GUSB c.866C>T 
variant was a plausible mutation. 
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The GUSB enzyme is a lysosomal homotetramer [110]. Both human and canine 
monomers consist of 651 amino acids. The structure of human GUSB has been well 
characterized and shown to contain three functional domains, comprised of residues 
22-223, 224-342 and 343-632 (Fig. 10B). The first domain of the GUSB monomer 
forms a distorted barrel-like structure with a jelly roll motif and two ?-hairpin loops; 
the second domain is similar to the immunoglobulin constant domains, and the third 
forms the active enzyme site with ???- or TIM-barrel motif [146]. The canine GUSB 
protein  is  81%  similar  to  human  GUSB  at  the  amino  acid  level  [120]  and  we  can  
assume that the domain structure is similar as well. The identified p.P289L 
substitution of GUSB in the affected Brazilian Terriers resides in the middle of the 
second domain (Fig. 10B,C). Multiple alignments performed across eukaryotic and 
prokaryotic species indicated that the substitution site and its surrounding residues 
are  well  conserved  (IV/Fig.  5).  The  disruption  of  the  conserved  region  by  the  
substitution is likely to impair the GUSB structure and thus function. This was 
further supported by a bioinformatic analysis of the substitution with PolyPhen-2 
software. The effect of the mutation was predicted to be “probably damaging” with a 
maximum score of 1.0.  
 
Figure 10.  Canine GUSB has 12 exons. C.866C>T mutation (arrow) is located in the exon 5 
(A) and forms a p.P289L substitution in the middle of the third domain of GUSB 
protein (B). The p.P289L substitution site is marked as green in a ribbon model of 
GUSB monomer (C).  
A cohort of 202 Brazilian Terriers comprising of 15 cases and 187 controls was 
genotyped in order to confirm the association of the c.866C>T mutation with the 
disease (IV/Table S1).  As expected, all affected dogs were homozygous and all 
obligatory carriers (n=12) were heterozygous for the variant. The carrier frequency 
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among the control population was 28.3%. The results confirmed a significant 
association of the c.866C>T variant with the disease (p=7.71 x 10-29). In addition, a 
set of 166 dogs from 36 different breeds was genotyped to further confirm the 
causality of the mutation (IV/ Table S1). None of these dogs carried the mutation. 
The complete segregation of the mutation according to the recessive mode of 
inheritance validates the disease locus identified through GWA. 
4.4.4 Elevated urinary GAGs and substantially decreased ?-
glucuronidase activity in the the affected dogs confirm the 
pathogenity of the mutation 
Deficiency of GAG degradating enzymes, including ?-glucuronidase, leads to 
accumulation of GAGs and subsequently to elevated excretion of GAGs into urine. 
Therefore, the quantitative measurement of urinary GAGs is commonly used in 
screening patients for mucopolysaccharidosis. In order to confirm the detrimental 
effect of the mutation, urinary GAGs were measured from three affected puppies (~6 
weeks of age) and three healthy age-and breed-matched wild-type controls (IV/Table 
S2). The affected dogs had a 2.7-fold increase in GAG levels. In addition, the 
activity of ?-glucuronidase was determined from the serum of the three affected dogs 
and  six  control  dogs  (three  carriers  and  three  wild-types)  (IV/Table  2).  In  the  
affected dogs, the enzyme activity was severely impaired with a mean residual 
activity of 0.2% compared with the wild-type dogs. Moreover, the carrier dogs also 
had a decreased level of enzyme activity (67%). These results confirmed the 
predicted pathogenic effect of the GUSB mutation and demonstrated that the disease 
in Brazilian Terriers is MPS VII.  
4.4.5 Identification of the mutation led to the development of genetic 
test for dogs and provides a large animal model of MPSVII for 
human medicine 
In conclusion, a canine disease causing prominent skeletal defects was described in 
this study and a mutation in the GUSB gene was identified to be causative. The 
evident features including multiple skeletal dysmorphisms, joint hyperlaxity and 
growth retardation in the affected Brazilian Terriers are consistent with the clinical 
signs in MPS VII affected dogs containing the p.R166H substitution in GUSB. Some 
typical signs of the disease such as corneal clouding, organomegaly and lysosomal 
vacuolization were not demonstrated in the MPS VII affected Brazilian Terriers in 
this study. This could be due to the early age of the puppies examined. The disease is 
progressive due to constantly increasing amount of undegraded GAGs in cells and 
tissues. Thus, systematic examination of the target organs and tissues of affected 
dogs at different ages might reveal additional features as well. 
This study is an example of a gene mapping resulting in extensive association 
due to the use of closely related dogs of small inbred population. Number of affected 
dogs was limited and there was no possibility to take advantage of other breeds to be 
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used in fine-mapping. This challenged the mutation identification as the critical 
disease-associated region extended over 13 Mb with over 220 genes. However, using 
the latest gene technology to capture and resequence the entire associated region, the 
causative GUSB mutation was successfully identified.  Consequently, the mutation 
defined the disease as mucopolysaccharidosis VII establishing a novel canine model 
for the disease. Enzyme replacement therapy (ERT) and hematopoietic stem cell 
transplantation (HSCT) have been used as a treatment for several MPSs in human 
patients [147]. For example, MPS I (Hurler disease) patients are successfully treated 
by both ERT and HSCT [148,149]. However, there is no efficient treatment available 
for MPS VII for the moment; there are very few data and no convincing results about 
the use of bone marrow transplantation for MPS VII [150], whereas ERT for MPS 
VII has been mentioned to be in development [147]. Interestingly, gene therapy has 
been quite successfully performed in dogs with MPS VII. It has been demonstrated 
that neonatal intravenous injection of gamma retroviral vector expressing GUSB in 
dogs significantly increases lifespan, reduces skeletal abnormalities, and improves 
the mobility throughout the lives of MPS VII dogs [151-154]. The dogs with the 
GUSB mutation identified in this study could as well be exploited for the 
development and validation of therapeutical methods. This could eventually be 
advantageous for both dogs and human patients.  
The pedigree data indicated that all affected dogs had a common Brazilian 
ancestor, suggesting that the GUSB mutation has arrived to the Brazilian Terrier 
population in Finland along with the dogs imported from Brazil. Since the discovery 
of the mutation, affected puppies have also been reported in Brazil. The mutation has 
not been found in other breeds so far, suggesting that it has occurred inside the 
Brazilian Terrier population. The GUSB mutation is yet another example of an 
ancestral mutation that has spread throughout the whole population of the breed. 
Identification of the mutation enabled the development of a genetic test to eradicate 
the disease from the breed. The carrier frequency in the study cohort was high, 
nearly  30%.  As  a  result  of  this  study  genetic  testing  of  GUSB mutation  in  dogs  is  
now  possible.  With  the  help  of  genetic  testing  it  is  possible  to  avoid  the  disease  
manifestations while retaining the carrier dogs in breeding and thus maintaining the 
genetic diversity.  
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5 Concluding remarks 
This study is rich in methodology, covers different fields of science including 
genetics, molecular biology, developmental biology and veterinary medicine, and 
has several theoretical and practical implications. Unique canine genomic system has 
been efficiently utilized here, along with genomic resources, to identify new genes in 
developmental and disease traits. This study combines clinical and basic research to 
describe new disease phenotypes and to characterize their genetic causes. In addition 
to new genes, a new disease mechanism and biological pathway that regulate 
important developmental processes have been revealed. The clinical and genetic 
similarities of canine and human disease are demonstrated in this work, and as such, 
new large animal models have been established for possible therapeutic studies that 
may impact human medicine. Finally, this study has provided new tools for 
veterinary diagnostics and has changed breeding practices in the affected breeds for 
the improvement of their health.  
In the beginning of this study, the high quality assembly of canine genome had 
recently been annotated, providing the necessary genomic resources for gene 
mapping studies, including the first low-density SNP arrays. Using less than 30K 
SNPs, many monogenic loci were identified in small sample cohorts but mapping of 
the susceptibility loci in polygenic traits remained more challenging [155]. Current 
high-density arrays provide even better resolution and may help to identify loci for 
complex traits in larger study chorts. Combination of unique canine population 
structure and fast developing genetic tools for canine research has turned out to be a 
powerful recipe for discovery of genes. The next generation sequencing approaches 
are becoming routine in many research laboratories with appropriate bioinformatics 
and computational resources and may further boost canine genetics by improving 
resolution in studies.  
Many of the mutations causing breed characteristic phenotypes have arisen a 
long time ago and drifted to several different populations as these characteristics 
ended up being favoured by man in many breeds. Two examples of these ancestral 
mutations were included in this study; T mutation causing short tail in several 
breeds, and FOXI3 mutation causing the hairless phenotype in three breeds. Both of 
these represent mutations, which result in the desired phenotype as heterozygous but 
lethality as homozygous. This study confirmed the lethality of these homozygous 
mutations and thus has had an impact on the breeding practices of the involved 
breeds. The breeders are now aware of the possible effects of these mutations and the 
inheritance. The breeding of two short-tailed dogs has been prohibited in the breeds 
with T mutation due to the possibility of producing severely defected puppies. What 
comes to the Mexican and Peruvian Hairless dogs, the coated representatives of the 
breeds have been accepted as part of the breeding program. 
This study demonstrates the characteristics of the canine genomic system. The 
population bottlenecks created during domestication and creation of modern breeds 
established a specific population structure seen today in the canine genome. The 
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typical canine genome is featured by long LDs within the breed and short LDs across 
the breeds, which facilitates gene mapping if the studied phenotype exists in several 
breeds. This genomic feature could be exploited while searching the mutation for the 
CED in different hairless breeds. As expected the additional breeds improved the 
resolution in the associated region first mapped within a breed.  
Inbred populations are powerful for gene mapping but may result in extensive 
association that challenges the mutation discovery. This was experienced in the 
small Brazilian Terrier breed, in which the critical disease-associated region 
extended over 13 Mb with over 220 genes. Without any possibility to use other 
breeds for fine mapping, it presented a remarkable challenge to identify the mutation 
in the gene rich region. However, using the latest gene technology to capture and 
resequence the entire associated region, the causative GUSB mutation was 
successfully identified.   
This study has several practical implications. Two genetic tests have been 
developed to assist breeders to avoid the detrimental conditions in the breeds. 
Genetic testing for MPS VII enables the eradication of the lethal skeletal condition 
from Brazilian Terriers and represents a striking example of how a small breed with 
a limited genetic diversity can benefit from genetic research and genetic testing. The 
prevalence of the mutation carriers was very high in the breed (28%) and now 
affected dogs can be avoided. Moreover, the carrier dogs can be safely preserved in 
breeding programs to maintain the limited gene pool.  
The genetic testing of T mutation has found its place in breeding plans, although 
the phenotype is a favored characteristic in many breeds. The reason for the use of 
the genetic testing is that tail docking is prohibited in several countries, including 
Finland. Therefore a dog that has a bobtail and belongs to one of the breeds that have 
the T mutation, has to have a certificate based on either a veterinary examination or 
now, a genetic test to prove its congenitaly. This study has endorsed changes in the 
breeding recommendations. Breeding of of two short-tailed dogs has been prohibited 
since 2009 by the Finnish Kennel Club, since it may result in the born of severely 
affected puppies. Genetic testing can now resolve uncertain cases, for instance if a 
short-tailed dog has been exported from a country where tail docking is allowed the 
genetic test is the only way to tell whether the dog is a natural bobtail. This study has 
also significantly extended the list of breeds that benefit from the genetic testing for 
short tail. 
This study demonstrates the value of canine models to developmental biology. 
The extent of morphological variation in dogs is unique and different dog breeds 
carry numerous interesting phenotypes for developmental biology. Some of the traits 
are fixed in the breeds and can be efficiently mapped by across breed approaches 
such as sweep mapping. Some conditions are harmful or even lethal and often breed-
specific as evidenced in this study. The causative mutation has been identified only 
for the fraction of the existing morphological traits and more traits are continuously 
being characterized. Dog breeds contain a wealth of valuable genetic information for 
developmental biologists and geneticists and offer possibilities to find new genes and 
pathways for comparative studies across species including human.  
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This study also has an impact on human medicine by providing new candidate 
genes for corresponding human conditions and by establishing a new large animal 
model for potential therapeutic purposes. The two genes studied here, T and FOXI3, 
do not yet have clear association to equivalent diseases in humans. However, both 
genes have been shown to play essential roles in several developmental processes. 
Furthermore, the detrimental effect of the mutations in these genes leading to 
embryonic lethality might even be the reason for the lack of identified human 
mutations.  Instead, the canine MPS VII could be considered as a worthy model for 
human disease. Whereas some forms of mucopolysaccharidoses have been treated 
with enzyme replacement therapies, there is no efficient treatment for MPS VII. The 
affected Brazilian Terriers could potentially serve as models for the development of 
therapy for this type of MPS.     
Future follow-up experiments are currently focused on the role and regulation of 
Foxi3 in ectodermal processes. A transgenic mouse model has already been 
developed and several lines of functional analyses are ongoing. The knowledge 
about the role of Foxi3 in different organ systems will be of great interest to 
developmental scientists. Notably, histological examination of selected tissues of 
dogs with CED has also been performed very recently and more phenotyping studies 
could bring some new information of the correlations of the Foxi3 genotype and 
phenotypes  across  species.  It  will  also  be  interesting  to  see  whether  any  FOXI3 
mutations will be found in human ectodermal dyplasia patients or perhaps in the 
cases of other diseases. Other future experiments may relate to the mapping the 
genes for the short-tail phenotype in the breeds not harbouring the T mutation. 
Identification of the causative genes, whether novel or not, could indicate their 
developmental roles not only in tail morphology but possibly behind other traits as 
well.    
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